DE635692C
(en)
|
|
1936-09-22 |
Herbert Zadow |
Medical syringe
|
US1655158A
(en)
|
1926-09-08 |
1928-01-03 |
Radium Emanation Corp |
Instrument for implanting radon seeds
|
FR640907A
(en)
|
1927-06-25 |
1928-07-24 |
|
Automatic flow limiter
|
US2168437A
(en)
|
1935-04-10 |
1939-08-08 |
Kenneth O Buercklin |
Injection device
|
US2110208A
(en)
|
1937-02-12 |
1938-03-08 |
U S Standard Products Company |
Antigen preparations
|
US2531724A
(en)
*
|
1948-09-20 |
1950-11-28 |
Edmund D Cevasco |
Infant bath mat
|
US2643653A
(en)
|
1951-07-19 |
1953-06-30 |
Heidrich John |
Pill injector
|
US3016895A
(en)
|
1958-08-01 |
1962-01-16 |
Pan American Lab Inc |
Injector for subcutaneous implantation of solids
|
US3025991A
(en)
|
1960-05-23 |
1962-03-20 |
Carron Products Co |
Bottle stopper
|
US3523906A
(en)
|
1962-07-11 |
1970-08-11 |
Gevaert Photo Prod Nv |
Process for encapsulating water and compounds in aqueous phase by evaporation
|
GB1049104A
(en)
|
1963-05-11 |
1966-11-23 |
Prodotti Antibiotici Spa |
Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
|
US3122162A
(en)
|
1963-06-20 |
1964-02-25 |
Asa D Sands |
Flow control device
|
US3538916A
(en)
|
1968-12-19 |
1970-11-10 |
Joseph S Wiles |
Injection pistol
|
US3691090A
(en)
|
1969-01-16 |
1972-09-12 |
Fuji Photo Film Co Ltd |
Encapsulation method
|
US3620216A
(en)
|
1969-06-25 |
1971-11-16 |
Abbott Lab |
Implant trocar
|
US3632768A
(en)
|
1969-10-02 |
1972-01-04 |
Upjohn Co |
Therapeutic composition and method for treating infections with actinospectacin
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US3737337A
(en)
|
1970-03-04 |
1973-06-05 |
Bayer Ag |
Process for the production of microgranulates
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
US3669104A
(en)
|
1970-06-15 |
1972-06-13 |
Pfizer |
Implant gun
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US3732865A
(en)
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
US3766915A
(en)
|
1971-12-21 |
1973-10-23 |
Illinois Tool Works |
Plastic needle holder
|
US3891570A
(en)
|
1972-01-26 |
1975-06-24 |
Toyo Jozo Kk |
Process for preparing microcapsules
|
US3869549A
(en)
|
1972-02-17 |
1975-03-04 |
Ciba Geigy Corp |
Injectable oily peptide preparations and processes for their manufacture
|
US3797492A
(en)
|
1972-12-27 |
1974-03-19 |
Alza Corp |
Device for dispensing product with directional guidance member
|
US3995632A
(en)
|
1973-05-04 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser
|
US3960757A
(en)
|
1973-06-27 |
1976-06-01 |
Toyo Jozo Co., Ltd. |
Process for encapsulation of medicaments
|
GB1518683A
(en)
|
1974-07-05 |
1978-07-19 |
Sandoz Ltd |
Pharmaceutical compositions
|
US4221862A
(en)
|
1975-06-27 |
1980-09-09 |
Fuji Photo Film Co., Ltd. |
Method of producing finely divided polymer particles
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
US4203439A
(en)
|
1976-11-22 |
1980-05-20 |
Alza Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4105030A
(en)
|
1977-01-03 |
1978-08-08 |
Syntex (U.S.A.) Inc. |
Implant apparatus
|
USD258837S
(en)
|
1977-10-17 |
1981-04-07 |
Gambro Dialysatoren Gmbh And Co. Kg |
Dialyzer cartridge
|
USD259458S
(en)
*
|
1978-06-09 |
1981-06-09 |
Fuller Charles R |
Support pad for an infant
|
US4223674A
(en)
|
1978-06-29 |
1980-09-23 |
Arthur J. McIntosh |
Implant gun
|
US4243030A
(en)
|
1978-08-18 |
1981-01-06 |
Massachusetts Institute Of Technology |
Implantable programmed microinfusion apparatus
|
US4305927A
(en)
|
1979-02-05 |
1981-12-15 |
Alza Corporation |
Method for the management of intraocular pressure
|
US4373527B1
(en)
|
1979-04-27 |
1995-06-27 |
Univ Johns Hopkins |
Implantable programmable medication infusion system
|
US4373527A
(en)
|
1979-04-27 |
1983-02-15 |
The Johns Hopkins University |
Implantable, programmable medication infusion system
|
US4310516A
(en)
|
1980-02-01 |
1982-01-12 |
Block Drug Company Inc. |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
|
US4384975A
(en)
|
1980-06-13 |
1983-05-24 |
Sandoz, Inc. |
Process for preparation of microspheres
|
EP0079405A1
(en)
|
1980-07-23 |
1983-05-25 |
Corless, Marion |
Apparatus for improving blood sugar control in diabetics
|
US4350271A
(en)
|
1980-08-22 |
1982-09-21 |
Alza Corporation |
Water absorbing fluid dispenser
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
US4451253A
(en)
|
1980-12-18 |
1984-05-29 |
Harman Sherman M |
Means and method for administering medicinals
|
US4340054A
(en)
|
1980-12-29 |
1982-07-20 |
Alza Corporation |
Dispenser for delivering fluids and solids
|
US4444498A
(en)
*
|
1981-02-27 |
1984-04-24 |
Bentley Laboratories |
Apparatus and method for measuring blood oxygen saturation
|
US4455145A
(en)
|
1981-07-10 |
1984-06-19 |
Alza Corporation |
Dispensing device with internal drive
|
USD271990S
(en)
*
|
1981-09-17 |
1983-12-27 |
Arthur W. Pulfer |
Baby bath
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
US4882166A
(en)
|
1981-09-30 |
1989-11-21 |
National Research Development Corporation |
Compositions comprising encapsulated particles and their preparation
|
US4727138A
(en)
|
1981-10-19 |
1988-02-23 |
Genentech, Inc. |
Human immune interferon
|
US4762791A
(en)
|
1981-10-19 |
1988-08-09 |
Genentech, Inc. |
Human immune interferon
|
US4929554A
(en)
|
1981-10-19 |
1990-05-29 |
Goeddel David V |
Human immune interferon
|
US4588614A
(en)
|
1981-10-20 |
1986-05-13 |
Adnovum Ag |
Pseudoplastic gel transfer
|
US4675184A
(en)
|
1981-11-28 |
1987-06-23 |
501 Sunstar Kabushiki Kaisha |
Pharmaceutical composition containing interferon in stable state
|
US5004689A
(en)
|
1982-02-22 |
1991-04-02 |
Biogen, Massachusetts |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4455143A
(en)
|
1982-03-22 |
1984-06-19 |
Alza Corporation |
Osmotic device for dispensing two different medications
|
US4695623A
(en)
|
1982-05-06 |
1987-09-22 |
Amgen |
Consensus human leukocyte interferon
|
US4897471A
(en)
|
1982-05-06 |
1990-01-30 |
Amgen |
Consensus human leukocyte interferon
|
US4820638A
(en)
|
1982-05-28 |
1989-04-11 |
Dr. Karl Thomae Gmbh |
Novel alpha interferon species produced by recombinant means
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4753651A
(en)
|
1982-08-30 |
1988-06-28 |
Alza Corporation |
Self-driven pump
|
US5795779A
(en)
|
1982-11-01 |
1998-08-18 |
Berlex Laboratories, Inc. |
Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells
|
US4552561A
(en)
|
1982-12-23 |
1985-11-12 |
Alza Corporation |
Body mounted pump housing and pump assembly employing the same
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
GB2138298B
(en)
|
1983-04-21 |
1986-11-05 |
Hundon Forge Ltd |
Pellet implanter
|
US4597753A
(en)
|
1983-04-21 |
1986-07-01 |
Hundon Forge Limited |
Implanting method and device
|
US4639244A
(en)
|
1983-05-03 |
1987-01-27 |
Nabil I. Rizk |
Implantable electrophoretic pump for ionic drugs and associated methods
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US4873080A
(en)
|
1983-06-08 |
1989-10-10 |
Dr. Karl Thomae Gmbh |
Oral anti-diabetic pharmaceutical compositions and the preparation thereof
|
US4743449A
(en)
|
1983-09-12 |
1988-05-10 |
Fujisawa Pharmaceutical Co., Ltd. |
Drug-containing lipid vesicle preparation and method for preparing them
|
US4594108A
(en)
|
1983-09-19 |
1986-06-10 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions
|
US5385738A
(en)
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
US5639640A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
DNA encoding the beta subunit of human follide stimulating hormone and expression vectors and cells containing same
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
US5767251A
(en)
|
1983-11-02 |
1998-06-16 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
|
US5690925A
(en)
|
1983-12-16 |
1997-11-25 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
US5574137A
(en)
|
1983-12-16 |
1996-11-12 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
US5120832A
(en)
|
1984-08-27 |
1992-06-09 |
Genentech, Inc. |
Distinct family of human leukocyte interferons
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
US4927687A
(en)
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
US5411951A
(en)
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
US4940588A
(en)
|
1984-10-30 |
1990-07-10 |
Elan Corporation |
Controlled release powder and process for its preparation
|
US4952402A
(en)
|
1984-10-30 |
1990-08-28 |
Elan Corporation, P.L.C. |
Controlled release powder and process for its preparation
|
US5605688A
(en)
|
1984-12-18 |
1997-02-25 |
Boehringer Ingelheim International Gmbh |
Recombinant dog and horse type I interferons
|
US4655462A
(en)
|
1985-01-07 |
1987-04-07 |
Peter J. Balsells |
Canted coiled spring and seal
|
EP0521586A1
(en)
|
1985-01-30 |
1993-01-07 |
Applied Research Systems ARS Holding N.V. |
FSH and other recombinant hormones
|
US4734284A
(en)
|
1985-02-19 |
1988-03-29 |
Nippon Kayaku Kabushiki Kaisha |
Etoposide preparations
|
US4820267A
(en)
|
1985-02-19 |
1989-04-11 |
Endocon, Inc. |
Cartridge injector for pellet medicaments
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4885166A
(en)
|
1985-06-11 |
1989-12-05 |
Ciba-Geigy Corporation |
Hybrid interferons
|
US4845196A
(en)
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
US4847079A
(en)
|
1985-07-29 |
1989-07-11 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal
|
US4818517A
(en)
|
1986-01-24 |
1989-04-04 |
Akzo N.V. |
Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
|
US4917887A
(en)
|
1986-03-10 |
1990-04-17 |
Boehringer Ingelheim International Gmbh |
Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
US4737437A
(en)
|
1986-03-27 |
1988-04-12 |
East Shore Chemical Co. |
Light sensitive diazo compound, composition and method of making the composition
|
US5958909A
(en)
|
1986-05-05 |
1999-09-28 |
The General Hospital Corporation |
Insulinotropic hormones and uses thereof
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
EP0254394A1
(en)
|
1986-06-16 |
1988-01-27 |
Alza Corporation |
Dosage form for delivering a drug comprising solubility regulating member
|
US5071642A
(en)
|
1986-10-23 |
1991-12-10 |
Dr. Rentschler Arzneimittel Gmbh & Co. |
Dihydropyridine containing compositions
|
US5019382A
(en)
|
1986-11-06 |
1991-05-28 |
The Texas A&M University System |
Treatment of immuno-resistant disease with low-dose interferon
|
US6372218B1
(en)
|
1986-11-06 |
2002-04-16 |
The Texas A&M University System |
Interferon dosage form and method therefor
|
US5602010A
(en)
|
1986-12-10 |
1997-02-11 |
Boehringer Ingelheim International Gmbh |
DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides
|
US4871094A
(en)
|
1986-12-31 |
1989-10-03 |
Alcon Laboratories, Inc. |
Means and method for dispensing substances
|
US5371089A
(en)
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
FR2616665A2
(en)
|
1987-03-16 |
1988-12-23 |
Denance Raymond |
Stabiliser adaptor for hypodermic needle, for adjusting penetration as a function of the angle of attack, formed from a needle guard
|
US4994028A
(en)
|
1987-03-18 |
1991-02-19 |
Endocon, Inc. |
Injector for inplanting multiple pellet medicaments
|
US4834708A
(en)
|
1987-03-31 |
1989-05-30 |
George Pillari |
Puncture needle assembly
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
EP0295411A1
(en)
|
1987-05-15 |
1988-12-21 |
Sansho Co., Ltd. |
Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US4940465A
(en)
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US5938654A
(en)
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
US4874388A
(en)
|
1987-06-25 |
1989-10-17 |
Alza Corporation |
Multi-layer delivery system
|
US4915949A
(en)
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4957119A
(en)
|
1987-08-08 |
1990-09-18 |
Akzo N.V. |
Contraceptive implant
|
EP0304107A1
(en)
|
1987-08-18 |
1989-02-22 |
Akzo N.V. |
Implant injection device
|
US4915954A
(en)
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering a drug at two different rates
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
US4886668A
(en)
|
1987-09-24 |
1989-12-12 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump
|
US5204108A
(en)
|
1987-10-10 |
1993-04-20 |
Danbiosyst Uk Ltd. |
Transmucosal formulations of low molecular weight peptide drugs
|
WO1989003678A1
(en)
|
1987-10-30 |
1989-05-05 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
US4917895A
(en)
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4907788A
(en)
|
1988-04-25 |
1990-03-13 |
Peter J. Balsells |
Dual concentric canted-coil spring apparatus
|
US4934666A
(en)
|
1988-04-25 |
1990-06-19 |
Peter J. Balsells |
Coiled spring electromagnetic shielding gasket
|
US4974821A
(en)
|
1988-04-25 |
1990-12-04 |
Peter J. Balsells |
Canted-coil spring with major axis radial loading
|
US4915366A
(en)
|
1988-04-25 |
1990-04-10 |
Peter J. Balsells |
Outside back angle canted coil spring
|
US5134244A
(en)
|
1988-04-25 |
1992-07-28 |
Peter J. Balsells |
Electromagnetic shielding seal for rotary/reciprocating shaft
|
US4876781A
(en)
|
1988-04-25 |
1989-10-31 |
Peter J. Balsells |
Method of making a garter-type axially resilient coiled spring
|
US4830344A
(en)
|
1988-04-25 |
1989-05-16 |
Peter J. Balsells |
Canted-coil spring with turn angle and seal
|
US4964204A
(en)
|
1988-04-25 |
1990-10-23 |
Peter J. Balsells |
Method for making a garter-type axially-resilient coil spring
|
US5117066A
(en)
|
1988-04-25 |
1992-05-26 |
Peter J. Balsells |
Retaining and locking electromagnetic gasket
|
US4961253A
(en)
|
1988-04-25 |
1990-10-09 |
Peter J. Balsells |
Manufacturing method for canted-coil spring with turn angle and seal
|
US5108078A
(en)
|
1988-04-25 |
1992-04-28 |
Peter J. Balsells |
Canted-coil spring loaded while in a cavity
|
US4826144A
(en)
|
1988-04-25 |
1989-05-02 |
Peter J. Balsells |
Inside back angle canted coil spring
|
US5006346A
(en)
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5160743A
(en)
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
JPH02124814A
(en)
|
1988-07-05 |
1990-05-14 |
Takeda Chem Ind Ltd |
Sustained release microcapsule containing water-soluble drug
|
US4893795A
(en)
|
1988-08-15 |
1990-01-16 |
Peter J. Balsells |
Radially loaded canted coiled spring with turn angle
|
EP0368339A2
(en)
|
1988-11-11 |
1990-05-16 |
Eisai Co., Ltd. |
Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt
|
EP0373867A1
(en)
|
1988-12-13 |
1990-06-20 |
Alza Corporation |
Delivery system comprising means for governing fluid ingress into the system
|
US5728088A
(en)
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5110596A
(en)
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5320616A
(en)
|
1988-12-13 |
1994-06-14 |
Alza Corporation |
Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5234424A
(en)
|
1988-12-28 |
1993-08-10 |
Alza Corporation |
Osmotically driven syringe
|
US4969884A
(en)
|
1988-12-28 |
1990-11-13 |
Alza Corporation |
Osmotically driven syringe
|
US4976966A
(en)
|
1988-12-29 |
1990-12-11 |
Alza Corporation |
Delayed release osmotically driven fluid dispenser
|
US5066436A
(en)
|
1989-01-04 |
1991-11-19 |
Gist-Brocades N.V. |
Process for microencapsulation
|
EP0379147B1
(en)
|
1989-01-17 |
1994-09-28 |
Sterling Winthrop Inc. |
Extrudable elastic gel for use as carrier for therapeutic agent
|
US5738845A
(en)
|
1989-03-02 |
1998-04-14 |
The Women's Research Institute |
Human interferon τ proteins and methods of use
|
US5942223A
(en)
|
1989-03-02 |
1999-08-24 |
University Of Florida |
Antiviral therapy using ovine or bovine interferon-tau
|
US5219572A
(en)
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
NL9000948A
(en)
|
1989-04-21 |
1990-11-16 |
Nedap Nv |
Injection and implanting instrument for coding or numbering animals - has handle sliding on guide pin with insertion depth stop parallel to hollow needle and anatomically shaped locating plate
|
NL8901004A
(en)
|
1989-04-21 |
1990-11-16 |
Nedap Nv |
Positioning attachment for animal implanting or injecting tool - has automatically shaped transparent positioning piece with adjustable needle insertion depth
|
US5090962A
(en)
|
1989-04-28 |
1992-02-25 |
Flp Enterprises, Inc. |
Non-reusable syringe
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
WO1990013780A1
(en)
|
1989-05-01 |
1990-11-15 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
WO1990013285A1
(en)
|
1989-05-01 |
1990-11-15 |
Enzytech, Inc. |
Process for producing small particles of biologically active molecules
|
US5407609A
(en)
|
1989-05-04 |
1995-04-18 |
Southern Research Institute |
Microencapsulation process and products therefrom
|
WO1990013361A1
(en)
|
1989-05-04 |
1990-11-15 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
US5445829A
(en)
|
1989-05-05 |
1995-08-29 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5126142A
(en)
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5192273A
(en)
|
1989-07-24 |
1993-03-09 |
Steven F. Bierman |
Catheterization system
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
US5336505A
(en)
|
1989-08-28 |
1994-08-09 |
Pharmaceutical Delivery Systems |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5660847A
(en)
|
1989-09-14 |
1997-08-26 |
Alza Corporation |
Implantable delivery dispenser comprising exit port
|
US5284655A
(en)
|
1989-09-21 |
1994-02-08 |
Osteotech, Inc. |
Swollen demineralized bone particles, flowable osteogenic composition containing same and use of the composition in the repair of osseous defects
|
US5614221A
(en)
|
1989-10-23 |
1997-03-25 |
Medivent |
Method of preparing a drug delivery system comprising a drug and a gel using a syringe
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
WO1991007160A1
(en)
|
1989-11-13 |
1991-05-30 |
Medicorp Holding S.A. |
Storage bottle containing a constituent of a medicinal solution
|
US5072070A
(en)
|
1989-12-01 |
1991-12-10 |
Peter J. Balsells |
Device for sealing electromagnetic waves
|
US5079388A
(en)
|
1989-12-01 |
1992-01-07 |
Peter J. Balsells |
Gasket for sealing electromagnetic waves
|
EP0431942A2
(en)
|
1989-12-06 |
1991-06-12 |
Sansho Co., Ltd. |
Percutaneously absorbable pharmaceutical preparation containing dopamine derivative
|
US5030216A
(en)
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
USD326718S
(en)
|
1989-12-26 |
1992-06-02 |
Minnesota Mining And Manufacturing Co. |
Blood sensor cassette
|
US5368863A
(en)
|
1990-01-24 |
1994-11-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5213809A
(en)
|
1990-01-24 |
1993-05-25 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
US5053014A
(en)
|
1990-02-01 |
1991-10-01 |
Critikon, Inc. |
Catheter with controlled valve
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
US5279554A
(en)
|
1990-02-09 |
1994-01-18 |
Rhone Merieux |
Implanting device
|
US5478564A
(en)
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
US5122128A
(en)
|
1990-03-15 |
1992-06-16 |
Alza Corporation |
Orifice insert for a ruminal bolus
|
US5160122A
(en)
|
1990-03-20 |
1992-11-03 |
Peter J. Balsells |
Coil spring with an elastomer having a hollow coil cross section
|
US5203849A
(en)
|
1990-03-20 |
1993-04-20 |
Balsells Peter J |
Canted coil spring in length filled with an elastomer
|
US5120306A
(en)
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5213810A
(en)
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
US5413572A
(en)
|
1990-04-02 |
1995-05-09 |
Alza Corporation |
Osmotic dosage system for liquid drug delivery
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5290271A
(en)
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
US5374620A
(en)
|
1990-06-07 |
1994-12-20 |
Genentech, Inc. |
Growth-promoting composition and its use
|
US5180591A
(en)
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234695A
(en)
|
1990-07-24 |
1993-08-10 |
Eastman Kodak Company |
Water dispersible vitamin E composition
|
US7008439B1
(en)
|
1990-09-21 |
2006-03-07 |
Datascope Investments Corp. |
Device and method for sealing puncture wounds
|
USD329278S
(en)
*
|
1990-10-01 |
1992-09-08 |
Gallup Allen I |
Infant's bathing support
|
US5300302A
(en)
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5151093A
(en)
|
1990-10-29 |
1992-09-29 |
Alza Corporation |
Osmotically driven syringe with programmable agent delivery
|
US5312389A
(en)
|
1990-10-29 |
1994-05-17 |
Felix Theeuwes |
Osmotically driven syringe with programmable agent delivery
|
US5122377A
(en)
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
US5700486A
(en)
|
1990-11-22 |
1997-12-23 |
Vectorpharma International S.P.A. |
Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions
|
EP0486959A1
(en)
|
1990-11-22 |
1992-05-27 |
Vectorpharma International S.P.A. |
Pharmaceutical composition of microparticles with controlled release and process of preparing it
|
US5279544A
(en)
|
1990-12-13 |
1994-01-18 |
Sil Medics Ltd. |
Transdermal or interdermal drug delivery devices
|
US5161806A
(en)
|
1990-12-17 |
1992-11-10 |
Peter J. Balsells |
Spring-loaded, hollow, elliptical ring seal
|
US5279608A
(en)
|
1990-12-18 |
1994-01-18 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Osmotic pumps
|
US5543156A
(en)
|
1991-01-09 |
1996-08-06 |
Alza Corporation |
Bioerodible devices and compositions for diffusional release of agents
|
US5147295A
(en)
|
1991-01-23 |
1992-09-15 |
Ideal Instruments, Inc. |
Retractable implanter
|
US5300079A
(en)
|
1991-01-30 |
1994-04-05 |
Texas Instruments Incorporated |
Injector
|
NL9100160A
(en)
|
1991-01-30 |
1992-08-17 |
Texas Instruments Holland |
INJECTOR.
|
US5443459A
(en)
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5531736A
(en)
|
1991-01-30 |
1996-07-02 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
EP0497575A1
(en)
|
1991-01-30 |
1992-08-05 |
Texas Instruments Holland B.V. |
Injector
|
US5395319A
(en)
|
1991-03-06 |
1995-03-07 |
Suddeutsche Feinmechanik Gmbh |
Needle for inserting an object into the body
|
US5861166A
(en)
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
WO1992019241A1
(en)
|
1991-05-07 |
1992-11-12 |
Dynagen, Inc. |
A controlled, sustained release delivery system for smoking cessation
|
US5113938A
(en)
|
1991-05-07 |
1992-05-19 |
Clayton Charley H |
Whipstock
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5711967A
(en)
|
1991-06-17 |
1998-01-27 |
Spirig Ag, Pharmazeutische Praeparate |
Oral diclofenac preparation
|
US5252338A
(en)
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5190765A
(en)
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US5541172A
(en)
|
1991-06-28 |
1996-07-30 |
Endorecherche, Inc. |
Controlled release systems and low dose androgens
|
US5288501A
(en)
|
1991-07-04 |
1994-02-22 |
Merz + Co. Gmbh & Co. |
Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
|
US5336057A
(en)
|
1991-09-30 |
1994-08-09 |
Nippon Densan Corporation |
Micropump with liquid-absorptive polymer gel actuator
|
US5352662A
(en)
|
1991-10-01 |
1994-10-04 |
Brooks Norman D |
Injectable extended release formulations and methods
|
WO1993006821A1
(en)
|
1991-10-04 |
1993-04-15 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release tablet
|
US5795591A
(en)
|
1991-10-10 |
1998-08-18 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
WO1993006819A1
(en)
|
1991-10-10 |
1993-04-15 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
WO1993008832A1
(en)
|
1991-11-08 |
1993-05-13 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
WO1993009763A1
(en)
|
1991-11-15 |
1993-05-27 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
US5511355A
(en)
|
1991-11-15 |
1996-04-30 |
Dingler; Gerhard |
Construction element
|
US5830501A
(en)
|
1991-12-06 |
1998-11-03 |
Alza Corporation |
Dosage form comprising hydrophilic polymer
|
US5312390A
(en)
|
1992-01-10 |
1994-05-17 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5223265A
(en)
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5658593A
(en)
|
1992-01-16 |
1997-08-19 |
Coletica |
Injectable compositions containing collagen microcapsules
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5308348A
(en)
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5209746A
(en)
|
1992-02-18 |
1993-05-11 |
Alza Corporation |
Osmotically driven delivery devices with pulsatile effect
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5428024A
(en)
|
1992-02-28 |
1995-06-27 |
Collagen Corporation |
High concentration homogenized collagen compositions
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
US5221278A
(en)
|
1992-03-12 |
1993-06-22 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
US5318558A
(en)
|
1992-03-12 |
1994-06-07 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
US5571525A
(en)
|
1992-03-30 |
1996-11-05 |
Alza Corporation |
Erosion rate modifier for use in bioerodible drug delivery devices and method of use
|
US5540912A
(en)
|
1992-03-30 |
1996-07-30 |
Alza Corporation |
Viscous suspensions of controlled-release drug particles
|
US5858746A
(en)
|
1992-04-20 |
1999-01-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
US6217908B1
(en)
|
1992-04-24 |
2001-04-17 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
US5429602A
(en)
|
1992-04-29 |
1995-07-04 |
Hauser; Jean-Luc |
Programmable portable infusion pump system
|
WO1993023083A1
(en)
|
1992-05-11 |
1993-11-25 |
Agouron Pharmaceuticals, Inc. |
Anhydrous formulations for administering lipophilic agents
|
US5250026A
(en)
|
1992-05-27 |
1993-10-05 |
Destron/Idi, Inc. |
Adjustable precision transponder injector
|
US5556642A
(en)
|
1992-07-16 |
1996-09-17 |
Tanabe Seiyaku Co., Ltd. |
Method for producing sustained release microsphere preparation
|
US5413672A
(en)
|
1992-07-22 |
1995-05-09 |
Ngk Insulators, Ltd. |
Method of etching sendust and method of pattern-etching sendust and chromium films
|
US5512293A
(en)
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
US5276926A
(en)
*
|
1992-08-04 |
1994-01-11 |
Raquel Lopez |
Baby bath and seat
|
US5279555A
(en)
|
1992-08-24 |
1994-01-18 |
Merck & Co., Inc. |
Device for injecting implants
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
US5827297A
(en)
|
1992-10-01 |
1998-10-27 |
Medicamat S.A. |
Device for transplanting small diameter hair grafts
|
WO1994009743A1
(en)
|
1992-11-05 |
1994-05-11 |
R.P. Scherer Corporation |
Vented capsule
|
EP0596161A1
(en)
|
1992-11-06 |
1994-05-11 |
Texas Instruments Incorporated |
Apparatus for subcutaneous introduction of a needle
|
WO1994010982A1
(en)
|
1992-11-17 |
1994-05-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release microsphere containing antipsychotic and process for producing the same
|
US5656299A
(en)
|
1992-11-17 |
1997-08-12 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained release microsphere preparation containing antipsychotic drug and production process thereof
|
US5871778A
(en)
|
1992-11-17 |
1999-02-16 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained release microsphere preparation containing antipsychotic drug
|
USD342855S
(en)
*
|
1992-11-20 |
1994-01-04 |
Butler Ii George D |
Combined infant cushion and cover
|
US5472708A
(en)
|
1992-11-27 |
1995-12-05 |
Andrx Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
US5635213A
(en)
|
1992-11-30 |
1997-06-03 |
Neopharma Production Ab |
Pharmaceutical formulation
|
US5667808A
(en)
|
1992-12-02 |
1997-09-16 |
Alkermes, Inc. |
Composition for sustained release of human growth hormone
|
US5654010A
(en)
|
1992-12-02 |
1997-08-05 |
Alkermes, Inc. |
Composition for sustained release of human growth hormone
|
US6528093B1
(en)
|
1992-12-07 |
2003-03-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US5589167A
(en)
|
1993-02-23 |
1996-12-31 |
Genentech, Inc. |
Excipient stabilization of polypeptides treated with organic solvents
|
US5368588A
(en)
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
WO1994021262A1
(en)
|
1993-03-17 |
1994-09-29 |
Alza Corporation |
Device for the transdermal administration of alprazolam
|
US5514110A
(en)
|
1993-03-22 |
1996-05-07 |
Teh; Eutiquio L. |
Automatic flow control device
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
JP2006213727A
(en)
|
1993-04-07 |
2006-08-17 |
Scios Inc |
Sustained release of peptide
|
US5630796A
(en)
|
1993-04-08 |
1997-05-20 |
Oxford Biosciences Limited |
Method of delivering powder transdermally with needless injector
|
US5843891A
(en)
|
1993-04-28 |
1998-12-01 |
Sherman; Bernard C. |
Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
|
EP0627231A2
(en)
|
1993-05-05 |
1994-12-07 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
US5997902A
(en)
|
1993-06-23 |
1999-12-07 |
Alza Corporation |
Ruminal drug delivery device
|
EP0631794A1
(en)
|
1993-06-23 |
1995-01-04 |
Hoechst Aktiengesellschaft |
Device for administering implants
|
US5639477A
(en)
|
1993-06-23 |
1997-06-17 |
Alza Corporation |
Ruminal drug delivery device
|
US5569289A
(en)
|
1993-06-24 |
1996-10-29 |
Yoon; Inbae |
Safety penetrating instrument with penetrating member and cannula moving during penetration and triggered safety member protusion
|
WO1995001167A2
(en)
|
1993-06-25 |
1995-01-12 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
US5498255A
(en)
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
US5486365A
(en)
|
1993-09-17 |
1996-01-23 |
Fuji Chemical Industry Co., Ltd. |
Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it
|
WO1995009007A1
(en)
|
1993-09-29 |
1995-04-06 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutynin
|
WO1995009006A1
(en)
|
1993-09-29 |
1995-04-06 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer
|
US5686097A
(en)
|
1993-09-29 |
1997-11-11 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for codelivery of steroids
|
US5558637A
(en)
|
1993-10-13 |
1996-09-24 |
Leiras Oy |
Implant injection device
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5770231A
(en)
|
1993-11-19 |
1998-06-23 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles
|
US5654008A
(en)
|
1993-11-19 |
1997-08-05 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
WO1995013799A1
(en)
|
1993-11-19 |
1995-05-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
US5688801A
(en)
|
1993-11-19 |
1997-11-18 |
Janssen Pharmaceutica |
Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
US5965168A
(en)
|
1993-11-19 |
1999-10-12 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
US5348544A
(en)
|
1993-11-24 |
1994-09-20 |
Becton, Dickinson And Company |
Single-handedly actuatable safety shield for needles
|
JPH07196479A
(en)
|
1994-01-04 |
1995-08-01 |
Unitika Ltd |
Method for producing microcapsule
|
USD358644S
(en)
|
1994-01-18 |
1995-05-23 |
Bio Medic Data Systems, Inc. |
Transponder implanter
|
US5540665A
(en)
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
US6022561A
(en)
|
1994-02-04 |
2000-02-08 |
Scotia Lipidteknik Ab |
Bilayers preparations
|
US5713847A
(en)
|
1994-02-09 |
1998-02-03 |
The University Of Iowa Research Foundation |
Human drug delivery device for tinnitus
|
US5810769A
(en)
|
1994-02-25 |
1998-09-22 |
Suddeutsche Feinmechanik Gmbh |
Cannula for the subcutaneous deposition of an object
|
JPH09509346A
(en)
|
1994-02-25 |
1997-09-22 |
ズードドイッチェ・フアインメハニーク・ゲーエムベーハー |
Cannula for subcutaneous fixation of target
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
US6007805A
(en)
|
1994-03-07 |
1999-12-28 |
Imperial College Of Science And Technology |
Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
|
US5484403A
(en)
|
1994-04-05 |
1996-01-16 |
Avid Marketing, Inc. |
Hypodermic syringe for implanting solid objects
|
US5660861A
(en)
|
1994-04-28 |
1997-08-26 |
Alza Corporation |
Effective therapy for epilepsies
|
WO1995034285A1
(en)
|
1994-06-13 |
1995-12-21 |
Alza Corporation |
Dosage form for administering drug in liquid formulation
|
EP0767689B1
(en)
|
1994-07-01 |
1999-06-02 |
Alza Corporation |
Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals
|
WO1996001134A1
(en)
|
1994-07-01 |
1996-01-18 |
Alza Corporation |
Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals
|
US5557318A
(en)
|
1994-07-12 |
1996-09-17 |
Koninklijke Ptt Nederland N.V. |
Method and apparatus for permitting a viewer to scan through a plurality of video signals provided by a transmitter
|
US5668170A
(en)
|
1994-07-13 |
1997-09-16 |
Alza Corporation |
Composition and method enhancing transdermal electrotransport agent delivery
|
WO1996003116A1
(en)
|
1994-07-25 |
1996-02-08 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release of metal cation-stabilized interferon
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5620705A
(en)
|
1994-08-04 |
1997-04-15 |
Alza Corporation |
Progestin tablet
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
US5695463A
(en)
|
1994-09-27 |
1997-12-09 |
Societe De Conseils De Recherches Et D'applications |
Safety injection device
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
US5836935A
(en)
|
1994-11-10 |
1998-11-17 |
Ashton; Paul |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
US5595759A
(en)
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
US5613954A
(en)
|
1994-11-21 |
1997-03-25 |
Stryker Corporation |
Laparoscopic surgical Y-tube cannula
|
EP0729747B1
(en)
|
1995-03-03 |
1997-05-07 |
L'oreal |
Use of amphiphilic compounds as thickening agent of non aqueous media and composition obtained
|
US5700583A
(en)
|
1995-03-06 |
1997-12-23 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters containing amines or amido groups
|
US5607687A
(en)
|
1995-03-06 |
1997-03-04 |
Ethicon, Inc. |
Polymer blends containing absorbable polyoxaesters
|
US5595751A
(en)
|
1995-03-06 |
1997-01-21 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/or amido groups
|
US6458385B2
(en)
|
1995-03-06 |
2002-10-01 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US5962023A
(en)
|
1995-03-06 |
1999-10-05 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US6372256B2
(en)
|
1995-03-06 |
2002-04-16 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US5859150A
(en)
|
1995-03-06 |
1999-01-12 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters
|
US5648088A
(en)
|
1995-03-06 |
1997-07-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amide groups
|
US20010026793A1
(en)
|
1995-03-06 |
2001-10-04 |
Jamiolkowski Dennis D. |
Hydrogels containing absorbable polyoxaamides
|
US20010021377A1
(en)
|
1995-03-06 |
2001-09-13 |
Jamiolkowski Dennis D. |
Hydrogels containing absorbable polyoxaamides
|
US5844017A
(en)
|
1995-03-06 |
1998-12-01 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
|
US5618552A
(en)
|
1995-03-06 |
1997-04-08 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US5620698A
(en)
|
1995-03-06 |
1997-04-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amido groups
|
US20010012511A1
(en)
|
1995-03-06 |
2001-08-09 |
Bezwada Rao S. |
Method of preventing adhesions with absorbable polyoxaesters
|
US6403655B1
(en)
|
1995-03-06 |
2002-06-11 |
Ethicon, Inc. |
Method of preventing adhesions with absorbable polyoxaesters
|
US5597579A
(en)
|
1995-03-06 |
1997-01-28 |
Ethicon, Inc. |
Blends of absorbable polyoxaamides
|
US6251435B1
(en)
|
1995-03-06 |
2001-06-26 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US5464929A
(en)
|
1995-03-06 |
1995-11-07 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US6100346A
(en)
|
1995-03-06 |
2000-08-08 |
Ethicon, Inc. |
Copolymers of polyoxaamides
|
US5645850A
(en)
|
1995-03-06 |
1997-07-08 |
Ethicon, Inc. |
Blending containing absorbable polyoxaamides
|
US6224894B1
(en)
|
1995-03-06 |
2001-05-01 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
US5698213A
(en)
|
1995-03-06 |
1997-12-16 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
US6147168A
(en)
|
1995-03-06 |
2000-11-14 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
US6060450A
(en)
|
1995-03-16 |
2000-05-09 |
University Of Florida |
Method for treatment of autoimmune diseases
|
US5906816A
(en)
|
1995-03-16 |
1999-05-25 |
University Of Florida |
Method for treatment of autoimmune diseases
|
US5697914A
(en)
|
1995-03-16 |
1997-12-16 |
Becton Dickinson And Company |
Control forward/flashback forward one hand introducer needle and catheter assembly
|
US5697113A
(en)
*
|
1995-03-23 |
1997-12-16 |
Aminach Bedding & Furniture Manufacturing Ltd. |
Ventilated infant's mattress
|
US5542682A
(en)
|
1995-03-27 |
1996-08-06 |
American Variseal |
Slant coil spring and seal
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
US5972373A
(en)
|
1995-05-02 |
1999-10-26 |
Taisho Pharmaceutical Co., Ltd. |
Taste masking pharmaceutical composition for oral administration
|
US5939286A
(en)
|
1995-05-10 |
1999-08-17 |
University Of Florida |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
|
WO1996036317A1
(en)
|
1995-05-18 |
1996-11-21 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US5882676A
(en)
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5718922A
(en)
|
1995-05-31 |
1998-02-17 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation
|
WO1996039142A1
(en)
|
1995-06-06 |
1996-12-12 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
|
WO1996040049A1
(en)
|
1995-06-07 |
1996-12-19 |
Alza Corporation |
Peptide/protein suspended formulations
|
US5972370A
(en)
|
1995-06-07 |
1999-10-26 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5690952A
(en)
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
US5876746A
(en)
|
1995-06-07 |
1999-03-02 |
Cygnus, Inc. |
Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
|
WO1996040355A1
(en)
|
1995-06-07 |
1996-12-19 |
Cygnus, Inc. |
Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
|
US5871770A
(en)
|
1995-06-07 |
1999-02-16 |
Alza Corporation |
Implantable system for delivery of fluid-sensitive agents to animals
|
US20040101557A1
(en)
|
1995-06-07 |
2004-05-27 |
Gibson John W. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
WO1996040139A1
(en)
|
1995-06-07 |
1996-12-19 |
Alza Corporation |
Novel formulations for transdermal delivery of pergolide
|
US5725497A
(en)
|
1995-06-07 |
1998-03-10 |
American Cyanamid Company |
Injection dart system
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
US6607529B1
(en)
|
1995-06-19 |
2003-08-19 |
Medtronic Vidamed, Inc. |
Electrosurgical device
|
US5782396A
(en)
|
1995-08-28 |
1998-07-21 |
United States Surgical Corporation |
Surgical stapler
|
US5906830A
(en)
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
US5814323A
(en)
|
1995-10-16 |
1998-09-29 |
Lever Brothers Company, Division Of Conopco, Inc. |
Cosmetic composition
|
US6120787A
(en)
|
1995-10-19 |
2000-09-19 |
Biogram Ab |
Sustained release particles
|
WO1997015296A1
(en)
|
1995-10-23 |
1997-05-01 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
WO1997015289A1
(en)
|
1995-10-25 |
1997-05-01 |
Cortecs (Uk) Limited |
Solubilisation methods
|
EP0771817A2
(en)
|
1995-10-30 |
1997-05-07 |
Laboratorios S.A.L.V.A.T., S.A. |
Fatty-acid monoesters of estrogens for the treatment of obesity and/or overweight
|
US6461605B1
(en)
|
1995-11-02 |
2002-10-08 |
Schering Corporation |
Continuous low-dose cytokine infusion therapy
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5906599A
(en)
|
1995-11-09 |
1999-05-25 |
Intermed, Inc. |
Device for delivering biological agents
|
US6190700B1
(en)
|
1995-12-15 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Production of sustained-release preparation for injection
|
US5851451A
(en)
|
1995-12-15 |
1998-12-22 |
Takeda Chemical Industries, Ltd. |
Production of microspheres
|
US6592508B1
(en)
|
1995-12-18 |
2003-07-15 |
Integrated Implant Systems, Llc |
Fiberoptic-guided interstitial seed manual applicator and seed cartridge
|
US6133249A
(en)
|
1995-12-19 |
2000-10-17 |
Macnaught Medical Pty Limited |
Phospholipid and propylene glycol based lubricant
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
US5672549A
(en)
|
1996-01-31 |
1997-09-30 |
Sumitomo Bakelite Company Limited |
Method of producing epoxy resin-encapsulated semiconductor device
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
WO1997028181A2
(en)
|
1996-02-02 |
1997-08-07 |
Rhomed Incorporated |
Post-labeling stabilization of radiolabeled proteins and peptides
|
US5728396A
(en)
|
1996-02-02 |
1998-03-17 |
Alza Corporation |
Sustained delivery of leuprolide using an implantable system
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
US7655257B2
(en)
|
1996-02-02 |
2010-02-02 |
Intarcia Therapeutics, Inc. |
Sustained delivery of an active agent using an implantable system
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6635268B2
(en)
|
1996-02-02 |
2003-10-21 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US20040039376A1
(en)
|
1996-02-02 |
2004-02-26 |
Peery John R. |
Sustained delivery of an active agent using an implantable system
|
US5985305A
(en)
|
1996-02-02 |
1999-11-16 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
WO1997031943A1
(en)
|
1996-03-01 |
1997-09-04 |
Novo Nordisk A/S |
Use of a pharmaceutical composition comprising an appetite-suppressing peptide
|
JPH09241153A
(en)
|
1996-03-04 |
1997-09-16 |
Q P Corp |
Lipid emulsion for intravenous injection
|
US6124281A
(en)
|
1996-03-08 |
2000-09-26 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
US6069133A
(en)
|
1996-03-14 |
2000-05-30 |
The Immune Response Corporation |
Targeted delivery of genes encoding interferon
|
US5703200A
(en)
|
1996-03-15 |
1997-12-30 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
|
US6190702B1
(en)
|
1996-03-28 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
US6074673A
(en)
|
1996-04-22 |
2000-06-13 |
Guillen; Manuel |
Slow-release, self-absorbing, drug delivery system
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US5976109A
(en)
|
1996-04-30 |
1999-11-02 |
Medtronic, Inc. |
Apparatus for drug infusion implanted within a living body
|
US6110503A
(en)
|
1996-05-07 |
2000-08-29 |
Alkermes Controlled Therapeutics Inc. |
Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
WO1997041837A2
(en)
|
1996-05-07 |
1997-11-13 |
Alkermes Controlled Therapeutics Inc. Ii |
Microparticles
|
US5916598A
(en)
|
1996-05-07 |
1999-06-29 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
|
WO1997044039A1
(en)
|
1996-05-20 |
1997-11-27 |
Janssen Pharmaceutica N.V. |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
WO1997046204A2
(en)
|
1996-06-05 |
1997-12-11 |
Ashmont Holdings Limited |
Injectable compositions
|
US6767887B1
(en)
|
1996-06-05 |
2004-07-27 |
Roche Diagnostics Gmbh |
Exendin analogues, processes for their preparation and medicaments containing them
|
WO1997047339A1
(en)
|
1996-06-14 |
1997-12-18 |
Filtertek, S.A. |
Gravity infusion set for medical infusions
|
US6258377B1
(en)
|
1996-07-02 |
2001-07-10 |
Provalis Uk Limited |
Hydrophobic preparations containing medium chain monoglycerides
|
WO1998000157A1
(en)
|
1996-07-03 |
1998-01-08 |
Alza Corporation |
Aqueous formulations of peptides
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
WO1998000158A1
(en)
|
1996-07-03 |
1998-01-08 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
WO1998000152A1
(en)
|
1996-07-03 |
1998-01-08 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US6235712B1
(en)
|
1996-07-03 |
2001-05-22 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
US6124261A
(en)
|
1996-07-03 |
2000-09-26 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
WO1998002169A2
(en)
|
1996-07-15 |
1998-01-22 |
Alza Corporation |
Novel formulations for the administration of fluoxetine
|
US6218431B1
(en)
|
1996-07-31 |
2001-04-17 |
Bayer Corporation |
Substituted biphenyls
|
US7521423B2
(en)
|
1996-08-08 |
2009-04-21 |
Amylin Pharmaceuticals, Inc. |
Exendin pharmaceutical compositions
|
US6858576B1
(en)
|
1996-08-08 |
2005-02-22 |
Amylin Pharmaceuticals, Inc. |
Methods for regulating gastrointestinal motility
|
US7741269B2
(en)
|
1996-08-08 |
2010-06-22 |
Amylin Pharmaceuticals, Inc. |
Exendins and exendin agonists for weight reduction and obesity
|
US8288338B2
(en)
|
1996-08-08 |
2012-10-16 |
Amylin Pharmaceuticals, Llc |
Exendin and exendin agonists for eating disorders
|
US7297761B2
(en)
|
1996-08-08 |
2007-11-20 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical compositions containing exendins
|
US20040266692A1
(en)
|
1996-08-08 |
2004-12-30 |
Young Andrew A. |
Exendin pharmaceutical compositions
|
WO1998007412A1
(en)
|
1996-08-21 |
1998-02-26 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release microparticles with a hydrophobic material
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
WO1998013091A1
(en)
|
1996-09-27 |
1998-04-02 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
WO1998013092A1
(en)
|
1996-09-27 |
1998-04-02 |
American Home Products Corporation |
Tissue penetration guide
|
US5984890A
(en)
|
1996-09-27 |
1999-11-16 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
US6074377A
(en)
|
1996-10-10 |
2000-06-13 |
Sanfilippo, Ii; Dominic Joseph |
Method of installing vascular access device
|
US6730328B2
(en)
|
1996-10-16 |
2004-05-04 |
Victoria Knepp Maskiewicz |
Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
|
WO1998016250A1
(en)
|
1996-10-16 |
1998-04-23 |
Alza Corporation |
Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
|
WO1998017315A2
(en)
|
1996-10-24 |
1998-04-30 |
Alza Corporation |
Permeation enhancers for transdermal drug delivery compositions, devices, and methods
|
US5817129A
(en)
|
1996-10-31 |
1998-10-06 |
Ethicon, Inc. |
Process and apparatus for coating surgical sutures
|
US6187095B1
(en)
|
1996-10-31 |
2001-02-13 |
Samsel K. Labrecque |
Process and apparatus for coating surgical sutures
|
US6191102B1
(en)
|
1996-11-05 |
2001-02-20 |
Eli Lilly And Company |
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
|
EP0841359A1
(en)
|
1996-11-06 |
1998-05-13 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
US6592887B2
(en)
|
1996-11-11 |
2003-07-15 |
Lts Lohmann Therapie-Systeme Ag |
Water soluble film for oral administration with instant wettability
|
US8865202B2
(en)
|
1996-11-11 |
2014-10-21 |
Lts Lohmann Therapie-Systeme Ag |
Water soluble film for oral administration with instant wettability
|
US6177096B1
(en)
|
1996-11-11 |
2001-01-23 |
Lts Lohmann Therapie-Systeme Gmbh |
Water soluble film for oral administration with instant wettability
|
US6709671B2
(en)
|
1996-11-11 |
2004-03-23 |
Lts Lohmann Therapie-Systeme Ag |
Water soluble film for oral administration with instant wettability
|
US6284264B1
(en)
|
1996-11-11 |
2001-09-04 |
Lts Lohmann Therapie-Systeme Gmbh |
Water soluble film for oral administration with instant wettability
|
US5948430A
(en)
|
1996-11-11 |
1999-09-07 |
Lts Lohmann Therapie-Systeme Gmbh |
Water soluble film for oral administration with instant wettability
|
US5928666A
(en)
|
1996-11-12 |
1999-07-27 |
Cygnus Inc. |
Crystalline form of estradiol and pharmaceutical formulations comprising same
|
WO1998020930A1
(en)
|
1996-11-15 |
1998-05-22 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
US6673767B1
(en)
|
1996-12-20 |
2004-01-06 |
Alza Corporation |
Gel composition and methods
|
US20030044467A1
(en)
|
1996-12-20 |
2003-03-06 |
Brodbeck Kevin J. |
Gel composition and methods
|
WO1998027963A2
(en)
|
1996-12-20 |
1998-07-02 |
Alza Corporation |
Gel composition and methods
|
US6130200A
(en)
|
1996-12-20 |
2000-10-10 |
Alza Corporation |
Gel composition and methods
|
WO1998027960A2
(en)
|
1996-12-20 |
1998-07-02 |
Bioglan Ireland (R & D) Limited |
A nitroimidazole gel composition
|
WO1998027962A2
(en)
|
1996-12-20 |
1998-07-02 |
Alza Corporation |
Injectable depot gel composition and method of preparing the composition
|
US6468961B1
(en)
|
1996-12-20 |
2002-10-22 |
Alza Corporation |
Gel composition and methods
|
US20020034532A1
(en)
|
1996-12-20 |
2002-03-21 |
Brodbeck Kevin J. |
Injectable depot gel composition and method of preparing the composition
|
US6331311B1
(en)
|
1996-12-20 |
2001-12-18 |
Alza Corporation |
Injectable depot gel composition and method of preparing the composition
|
US20060013879A9
(en)
|
1996-12-20 |
2006-01-19 |
Brodbeck Kevin J |
Gel composition and methods
|
WO1998030231A1
(en)
|
1997-01-07 |
1998-07-16 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the reduction of food intake
|
US6989366B2
(en)
|
1997-01-07 |
2006-01-24 |
Amylin Pharmaceuticals, Inc. |
Exendins, exendin agonists, and methods for their use
|
US7115569B2
(en)
|
1997-01-07 |
2006-10-03 |
Amylin Pharmaceuticals, Inc. |
Exendins, exendin agonists, and methods for their use
|
US7138375B2
(en)
|
1997-01-07 |
2006-11-21 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for lowering plasma lipid
|
US6956026B2
(en)
|
1997-01-07 |
2005-10-18 |
Amylin Pharmaceuticals, Inc. |
Use of exendins for the reduction of food intake
|
US20020137666A1
(en)
|
1997-01-07 |
2002-09-26 |
Nigel Robert Arnold Beeley |
Use of exendins and agonists thereof for the reduction of food intake
|
WO1998032463A2
(en)
|
1997-01-28 |
1998-07-30 |
Pharmacia & Upjohn Company |
Lyophilizate of lipid complex of water insoluble porphyrins
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
US6217906B1
(en)
|
1997-03-24 |
2001-04-17 |
Alza Corporation |
Self adjustable exit port
|
WO1998042317A2
(en)
|
1997-03-24 |
1998-10-01 |
Alza Corporation |
Implantable delivery device with self adjustable exit port
|
US5997527A
(en)
|
1997-03-24 |
1999-12-07 |
Alza Corporation |
Self adjustable exit port
|
US5874388A
(en)
|
1997-04-02 |
1999-02-23 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
|
US6127520A
(en)
|
1997-04-15 |
2000-10-03 |
Regents Of The University Of Michigan |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
|
WO1998047487A1
(en)
|
1997-04-17 |
1998-10-29 |
Dumex-Alpharma A/S |
A novel bioadhesive drug delivery system based on liquid crystals
|
US6217893B1
(en)
|
1997-04-18 |
2001-04-17 |
Pharma Biotech |
Sustained-release compositions and method for preparing same
|
US20040265273A1
(en)
|
1997-04-28 |
2004-12-30 |
Hong Li |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
WO1998051282A1
(en)
|
1997-05-13 |
1998-11-19 |
Imarx Pharmaceutical Corp. |
Solid porous matrices and methods of making and using the same
|
US20020004481A1
(en)
|
1997-06-13 |
2002-01-10 |
Jeffrey L. Cleland |
Controlled release microencapsulated ngf formulation
|
US6113947A
(en)
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
WO1998058698A1
(en)
|
1997-06-20 |
1998-12-30 |
Akzo Nobel N.V. |
Preloaded implantation device
|
WO1999003453A1
(en)
|
1997-07-14 |
1999-01-28 |
Lek, Tovarna Farmacevtskih In Kemic^¿Nih Izdelkov , D.D. |
Novel pharmaceutical formulation with controlled release of active substances
|
WO1999004768A2
(en)
|
1997-07-25 |
1999-02-04 |
Alza Corporation |
Osmotic delivery system flow modulator apparatus
|
WO1999004767A2
(en)
|
1997-07-25 |
1999-02-04 |
Alza Corporation |
Osmotic delivery system with semipermeable plug
|
US6840931B2
(en)
|
1997-07-25 |
2005-01-11 |
Alza Corporation |
Osmotic delivery system flow modulator apparatus and method
|
US6287295B1
(en)
|
1997-07-25 |
2001-09-11 |
Alza Corporation |
Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
US6524305B1
(en)
|
1997-07-25 |
2003-02-25 |
Alza Corporation |
Osmotic delivery system flow modulator apparatus and method
|
US20050131389A1
(en)
|
1997-07-25 |
2005-06-16 |
Peterson Lewis L. |
Osmotic delivery system flow modulator apparatus and method
|
US20010027311A1
(en)
|
1997-07-25 |
2001-10-04 |
Guohua Chen |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
US20030114837A1
(en)
|
1997-07-25 |
2003-06-19 |
Peterson Lewis L. |
Osmotic delivery system flow modulator apparatus and method
|
US6923800B2
(en)
|
1997-07-25 |
2005-08-02 |
Alza Corporation |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
US6478768B1
(en)
|
1997-08-08 |
2002-11-12 |
Gaplast Gmbh |
Implant syringe
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
WO1999012549A2
(en)
|
1997-09-09 |
1999-03-18 |
West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited |
Controlled release microsphere delivery system
|
US6023802A
(en)
*
|
1997-09-10 |
2000-02-15 |
King; Susan Melton |
Infant sleeper
|
US6172046B1
(en)
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
JPH11100353A
(en)
|
1997-09-29 |
1999-04-13 |
Esupo Kk |
Refined and deodorized liquid ester wax and its composition
|
WO1999016419A1
(en)
|
1997-09-29 |
1999-04-08 |
Inhale Therapeutic Systems, Inc. |
Perforated microparticles and methods of use
|
US6133429A
(en)
|
1997-10-03 |
2000-10-17 |
Becton Dickinson And Company |
Chromophores useful for the preparation of novel tandem conjugates
|
USD399821S
(en)
*
|
1997-11-07 |
1998-10-20 |
Motorola, Inc. |
Front section of a battery charger
|
WO1999025728A1
(en)
|
1997-11-14 |
1999-05-27 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
US6569420B2
(en)
|
1997-12-08 |
2003-05-27 |
Genentech, Inc. |
Human interferon-ε: a type I interferon
|
WO1999029306A1
(en)
|
1997-12-12 |
1999-06-17 |
Biohybrid Technologies, Inc. |
Devices for cloaking transplanted cells
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
US6375978B1
(en)
|
1997-12-22 |
2002-04-23 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
US20040243106A1
(en)
|
1997-12-29 |
2004-12-02 |
Rupal Ayer |
Osmotic delivery device with membrane plug retention mechanism
|
US20010021822A1
(en)
|
1997-12-29 |
2001-09-13 |
Rupal Ayer |
Osmotic delivery system with membrane plug retention mechanism
|
US6976981B2
(en)
|
1997-12-29 |
2005-12-20 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
US6190350B1
(en)
|
1997-12-29 |
2001-02-20 |
Alza Corporation |
Implanter device for subcutaneous implants
|
US6270787B1
(en)
|
1997-12-29 |
2001-08-07 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
WO1999033446A1
(en)
|
1997-12-29 |
1999-07-08 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
US20010022974A1
(en)
|
1997-12-29 |
2001-09-20 |
Rupal Ayer |
Osmotic delivery system with membrane plug retention mechanism
|
US6899887B2
(en)
|
1997-12-29 |
2005-05-31 |
Micron Technology, Inc. |
Osmotic delivery system with membrane plug retention mechanism
|
EP1300173A2
(en)
|
1997-12-29 |
2003-04-09 |
Alza Corporation |
Implanter device for subcutaneous implants
|
EP1300129A2
(en)
|
1997-12-29 |
2003-04-09 |
Alza Corporation |
Implant vial
|
US6113938A
(en)
|
1997-12-30 |
2000-09-05 |
Alza Corporation |
Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents
|
WO1999033449A1
(en)
|
1997-12-30 |
1999-07-08 |
Alza Corporation |
Beneficial agent delivery system with membrane plug
|
US20040024068A1
(en)
|
1998-01-23 |
2004-02-05 |
Trustees Of Tufts College |
Antimicrobial compounds
|
WO1999039700A1
(en)
|
1998-02-06 |
1999-08-12 |
Eurand International S.P.A. |
Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
|
US6017545A
(en)
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
WO1999040788A1
(en)
|
1998-02-13 |
1999-08-19 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and glp-1
|
US7928065B2
(en)
|
1998-02-13 |
2011-04-19 |
Amylin Pharmaceuticals, Inc. |
Methods of treatment using exendin peptides or GLP-1 peptides
|
US6402716B1
(en)
|
1998-02-20 |
2002-06-11 |
Lg Chemical Ltd. |
Syringe assembly
|
USD408917S
(en)
|
1998-02-26 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Membrane support structure of a flow through cell for blood gas measurement
|
WO1999044659A1
(en)
|
1998-03-02 |
1999-09-10 |
Medrad, Inc. |
Syringes and plungers for use therein
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
US20020136848A1
(en)
|
1998-03-12 |
2002-09-26 |
Fumio Yoshii |
Lactone-containing resin composition, molded object thereof, and film
|
US6029361A
(en)
|
1998-03-25 |
2000-02-29 |
Ultratech Stepper, Inc. |
Air-guage nozzle probe structure for microlithographic image focusing
|
US6395282B1
(en)
|
1998-04-16 |
2002-05-28 |
University Of Rochester |
Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
|
US6074660A
(en)
|
1998-04-20 |
2000-06-13 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/ or amido groups
|
WO1999062501A1
(en)
|
1998-05-29 |
1999-12-09 |
Sumitomo Pharmaceuticals Company, Limited |
Controlled release preparations having multi-layer structure
|
US7101567B1
(en)
|
1998-05-29 |
2006-09-05 |
Dainippon Sumitomo Pharma Co., Ltd. |
Controlled release preparations having multi-layer structure
|
EP1084703A1
(en)
|
1998-05-29 |
2001-03-21 |
Sumitomo Pharmaceuticals Company, Limited |
Controlled release preparations having multi-layer structure
|
WO1999064061A1
(en)
|
1998-06-12 |
1999-12-16 |
Bionebraska, Inc. |
GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
|
US6277413B1
(en)
|
1998-07-17 |
2001-08-21 |
Skyepharma, Inc. |
Biodegradable compositions for the controlled release of encapsulated substances
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
US20040225113A1
(en)
|
1998-07-21 |
2004-11-11 |
Lafleur David W. |
Keratinocyte derived interferon
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
USD415073S
(en)
*
|
1998-08-17 |
1999-10-12 |
ScooterBug, Inc. |
Stroller
|
US6720407B1
(en)
|
1998-08-28 |
2004-04-13 |
Eli Lilly And Company |
Method for administering insulinotropic peptides
|
US6551613B1
(en)
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
WO2000013663A1
(en)
|
1998-09-09 |
2000-03-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US5951521A
(en)
|
1998-09-25 |
1999-09-14 |
Minimed Inc. |
Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
|
US6645192B2
(en)
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
US20040047888A1
(en)
|
1998-09-30 |
2004-03-11 |
Kenison Dale C. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
US6447522B2
(en)
|
1998-09-30 |
2002-09-10 |
C. R. Bard, Inc. |
Implant delivery system
|
US6248112B1
(en)
|
1998-09-30 |
2001-06-19 |
C. R. Bard, Inc. |
Implant delivery system
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
US6053927A
(en)
*
|
1998-10-15 |
2000-04-25 |
Rsh-Gs Trust |
Apparatus and method for implant removal
|
US6544239B2
(en)
|
1998-10-16 |
2003-04-08 |
Bio-Plexus Delaware, Inc. |
Releasable locking needle assembly with optional release accessory therefor
|
US20020048600A1
(en)
|
1998-11-02 |
2002-04-25 |
Padmanabh Bhatt |
Controlled delivery of active agents
|
WO2000029206A1
(en)
|
1998-11-13 |
2000-05-25 |
Sensor Technologies Inc. |
Monodisperse preparations useful with implanted devices
|
US20040157951A1
(en)
|
1998-11-13 |
2004-08-12 |
Wolf David E. |
Monodisperse preparations useful with implanted devices
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
US6903186B1
(en)
|
1998-12-07 |
2005-06-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S |
Analogues of GLP-1
|
US20010036472A1
(en)
|
1998-12-17 |
2001-11-01 |
Wong Patrick S.-L. |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
US6419952B2
(en)
|
1998-12-17 |
2002-07-16 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
WO2000038652A1
(en)
|
1998-12-23 |
2000-07-06 |
Amgen Inc. |
Polyol/oil suspensions for the sustained release of proteins
|
US6544252B1
(en)
|
1998-12-31 |
2003-04-08 |
Alza Corporation |
Osmotic delivery system having space efficient piston
|
WO2000039280A2
(en)
|
1998-12-31 |
2000-07-06 |
Viragen, Inc. |
Leukocyte-derived interferon preparations
|
US6997922B2
(en)
|
1998-12-31 |
2006-02-14 |
Alza Corporation |
Osmotic delivery system having space efficient piston
|
WO2000040273A2
(en)
|
1999-01-08 |
2000-07-13 |
Vical Incorporated |
Treatment of viral diseases using an interferon omega expressing polynucleotide
|
US6703225B1
(en)
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
US6433144B1
(en)
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
US7153825B2
(en)
|
1999-01-14 |
2006-12-26 |
Amylin Pharmaceuticals, Inc. |
Methods for glucagon suppression using modified exendins
|
US6872700B1
(en)
|
1999-01-14 |
2005-03-29 |
Amylin Pharmaceuticals, Inc. |
Methods for glucagon suppression
|
US6902744B1
(en)
|
1999-01-14 |
2005-06-07 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist formulations and methods of administration thereof
|
US20090215694A1
(en)
|
1999-01-14 |
2009-08-27 |
Amylin Pharmaceuticals, Inc |
Lyophilized Formulations of Exendins and Exendin Agonist Analogs
|
WO2000041548A2
(en)
|
1999-01-14 |
2000-07-20 |
Amylin Pharmaceuticals, Inc. |
Methods for glucagon suppression
|
US20060069029A1
(en)
|
1999-01-14 |
2006-03-30 |
Kolterman Orville G |
Exendin analog formulations
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US8048438B2
(en)
|
1999-02-08 |
2011-11-01 |
Intarcia Therapeutics, Inc. |
Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US20080226689A1
(en)
|
1999-02-08 |
2008-09-18 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US20030108609A1
(en)
|
1999-02-08 |
2003-06-12 |
Berry Stephen A. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US8173150B2
(en)
|
1999-02-08 |
2012-05-08 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles
|
US20170119855A1
(en)
|
1999-02-08 |
2017-05-04 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US20110160708A1
(en)
|
1999-02-08 |
2011-06-30 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles
|
US8268341B2
(en)
|
1999-02-08 |
2012-09-18 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US8992961B2
(en)
|
1999-02-08 |
2015-03-31 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US20170319662A1
(en)
|
1999-02-08 |
2017-11-09 |
Intarcia Therapeutics Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US20080226625A1
(en)
|
1999-02-08 |
2008-09-18 |
Intarcia Therapeutics, Inc. |
Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles
|
US20150231256A1
(en)
|
1999-02-08 |
2015-08-20 |
Intarcia Therapeutics Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
WO2000045790A2
(en)
|
1999-02-08 |
2000-08-10 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US8372424B2
(en)
|
1999-02-08 |
2013-02-12 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
WO2000054745A2
(en)
|
1999-03-18 |
2000-09-21 |
Durect Corporation |
Devices and methods for pain management
|
WO2000059476A1
(en)
|
1999-04-05 |
2000-10-12 |
Pharmaceutical Discovery Corporation |
Methods for fine powder formation
|
US6670368B1
(en)
|
1999-04-06 |
2003-12-30 |
Astrazeneca Ab |
Pyrimidine compounds with pharmaceutical activity
|
EP1046399A1
(en)
|
1999-04-19 |
2000-10-25 |
Schering Corporation |
HCV combination therapy, containing ribavirin in association with antioxidants
|
WO2000066138A2
(en)
|
1999-04-30 |
2000-11-09 |
Bionebraska, Inc. |
Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
WO2000066087A2
(en)
|
1999-05-03 |
2000-11-09 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
WO2000067728A2
(en)
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
US6428517B1
(en)
|
1999-05-10 |
2002-08-06 |
Milestone Scientific, Inc. |
Hand-piece for injection device with a retractable and rotating needle
|
USD430671S
(en)
|
1999-05-10 |
2000-09-05 |
Shute Wallace B |
Obstetrical forceps
|
US6329336B1
(en)
|
1999-05-17 |
2001-12-11 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
US6593295B2
(en)
|
1999-05-17 |
2003-07-15 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
US6146139A
(en)
|
1999-06-01 |
2000-11-14 |
Harrison, Iii; Louis V. |
Forceps apparatus
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
US20030059376A1
(en)
|
1999-06-04 |
2003-03-27 |
Libbey Miles A. |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
US6485706B1
(en)
|
1999-06-04 |
2002-11-26 |
Delrx Pharmaceutical Corp. |
Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
|
US20060233841A1
(en)
|
1999-06-04 |
2006-10-19 |
Brodbeck Kevin J |
Implantable gel compositions and method of manufacture
|
US20010040326A1
(en)
|
1999-06-14 |
2001-11-15 |
Lord Corporation |
Resilient member with deformed element and method of forming same
|
US6833256B1
(en)
|
1999-06-22 |
2004-12-21 |
University Of Maryland |
Interferon tau mutants and methods for making them
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US7766924B1
(en)
|
1999-07-28 |
2010-08-03 |
Cardica, Inc. |
System for performing anastomosis
|
USD445975S1
(en)
*
|
1999-08-27 |
2001-07-31 |
Black & Decker, Inc. |
Base unit for a hand held vacuum cleaner
|
WO2001019345A1
(en)
|
1999-09-10 |
2001-03-22 |
Astrazeneca Ab |
Method to obtain microparticles
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
US6514500B1
(en)
|
1999-10-15 |
2003-02-04 |
Conjuchem, Inc. |
Long lasting synthetic glucagon like peptide {GLP-!}
|
WO2001028631A1
(en)
|
1999-10-15 |
2001-04-26 |
Deschutes Medical Products, Inc. |
Brachytherapy instrument and methods
|
US6887849B2
(en)
|
1999-10-15 |
2005-05-03 |
Conjuchem, Inc. |
Long lasting synthetic glucagon-like peptide {GLP-1}
|
US6821949B2
(en)
|
1999-10-15 |
2004-11-23 |
Conjuchem, Inc. |
Long lasting synthetic glucagon-like peptide (GLP-1)
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
WO2001028525A2
(en)
|
1999-10-21 |
2001-04-26 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents
|
US6436091B1
(en)
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
WO2001043528A2
(en)
|
1999-12-17 |
2001-06-21 |
Durect Corporation |
Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide
|
US6508808B1
(en)
|
1999-12-21 |
2003-01-21 |
Alza Corporation |
Valve for osmotic devices
|
US6682522B2
(en)
|
1999-12-21 |
2004-01-27 |
Alza Corporation |
Valve for osmotic devices
|
US20010031790A1
(en)
|
1999-12-22 |
2001-10-18 |
Beisswenger Paul J. |
Treatment for complications of type 2 diabetes
|
US6283949B1
(en)
|
1999-12-27 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Refillable implantable drug delivery pump
|
US6572890B2
(en)
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
WO2001051041A1
(en)
|
2000-01-13 |
2001-07-19 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
US20020012818A1
(en)
|
2000-01-19 |
2002-01-31 |
Sakari Ruppi |
Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction
|
US20030186858A1
(en)
|
2000-01-31 |
2003-10-02 |
Arentsen Anne Charlotte |
Crystallisation of a GLP-1 analogue
|
US20030138491A1
(en)
|
2000-02-10 |
2003-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US20030032947A1
(en)
|
2000-02-15 |
2003-02-13 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
US20030040699A1
(en)
*
|
2000-03-13 |
2003-02-27 |
Christine Talling |
Device for inserting implants
|
WO2001068168A1
(en)
|
2000-03-13 |
2001-09-20 |
Leiras Oy |
Device for inserting implants
|
US6579851B2
(en)
|
2000-03-14 |
2003-06-17 |
Amylin Pharmaceuticals, Inc. |
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
|
US20030211974A1
(en)
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US20010031940A1
(en)
|
2000-03-23 |
2001-10-18 |
Hans-Joachim Loos |
Device for administering implants
|
US20020098180A1
(en)
|
2000-03-24 |
2002-07-25 |
Huan-Yao Lei |
Fullerene pharmaceutical compositions for preventing or treating disorders
|
US9044209B2
(en)
|
2000-04-14 |
2015-06-02 |
Attenuex Technologies, Inc. |
Method of removing an inflated implant
|
WO2001078683A2
(en)
|
2000-04-19 |
2001-10-25 |
Genentech, Inc. |
Sustained release formulations comprising growth hormone
|
US20020001631A1
(en)
|
2000-04-19 |
2002-01-03 |
Franklin Okumu |
Sustained release formulations
|
US6992065B2
(en)
|
2000-04-19 |
2006-01-31 |
Genentech, Inc. |
Sustained release formulations
|
US6875748B2
(en)
|
2000-04-21 |
2005-04-05 |
Vical Incorporated |
Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
|
US6589157B2
(en)
|
2000-05-18 |
2003-07-08 |
Integrated Implant Systems, L.L.C. |
Drive mechanism for medical instrument
|
US6706689B2
(en)
|
2000-05-19 |
2004-03-16 |
Amylin Pharmaceuticals, Inc. |
Treatment of acute coronary syndrome with GLP-1
|
US6667061B2
(en)
|
2000-05-25 |
2003-12-23 |
Alkermes Controlled Therapeutics, Inc. |
Preparation of injectable suspensions having improved injectability
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US20030113380A1
(en)
|
2000-05-25 |
2003-06-19 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US7084243B2
(en)
|
2000-06-16 |
2006-08-01 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
US20020037309A1
(en)
|
2000-08-10 |
2002-03-28 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6547250B1
(en)
|
2000-08-21 |
2003-04-15 |
Westport Research Inc. |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing
|
US8454552B2
(en)
|
2000-08-24 |
2013-06-04 |
Cardiac Science Corporation |
Method for constructing an instrument with a covered bore for subcutaneous implantation
|
US20100331868A1
(en)
|
2000-08-24 |
2010-12-30 |
Bardy Gust H |
Method For Constructing An Instrument With A Two-Part Plunger For Subcutaneous Implantation
|
US8251946B2
(en)
|
2000-08-24 |
2012-08-28 |
Cardiac Science, Inc. |
Method for constructing an instrument with a two-part plunger for subcutaneous implantation
|
US20040115236A1
(en)
|
2000-10-06 |
2004-06-17 |
Chan Tai Wah |
Devices and methods for management of inflammation
|
WO2002028366A2
(en)
|
2000-10-06 |
2002-04-11 |
Durect Corporation |
Devices and methods for management of inflammation
|
US7727519B2
(en)
|
2000-11-03 |
2010-06-01 |
Intarcia Therapeutics, Inc. |
Method for treating hepatitis C virus with omega interferon
|
WO2002036072A2
(en)
|
2000-11-03 |
2002-05-10 |
Biomedicines, Inc. |
Method for short-term and long-term drug dosimetry
|
US20020197235A1
(en)
|
2000-11-03 |
2002-12-26 |
Moran Stanford Mark |
Method for short-term and long-term drug dosimetry
|
US20050201980A1
(en)
|
2000-11-03 |
2005-09-15 |
Moran Stanford M. |
Method for short-term and long-term drug dosimetry
|
WO2002067895A2
(en)
|
2000-11-16 |
2002-09-06 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
US6626863B1
(en)
|
2000-11-22 |
2003-09-30 |
Nusaf, L.L.C. |
Safety syringe
|
WO2002043800A2
(en)
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
US20050070883A1
(en)
|
2000-11-29 |
2005-03-31 |
Brown James E |
Devices and methods for controlled delivery from a drug delivery device
|
WO2002045752A2
(en)
|
2000-12-08 |
2002-06-13 |
Leo Pharma A/S |
Dermal anti-inflammatory composition
|
WO2002047716A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
US7199217B2
(en)
|
2000-12-13 |
2007-04-03 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
US8273713B2
(en)
|
2000-12-14 |
2012-09-25 |
Amylin Pharmaceuticals, Llc |
Methods of treating obesity using PYY[3-36]
|
US20020141985A1
(en)
|
2000-12-14 |
2002-10-03 |
Amylin Parmaceuticals, Inc. |
Peptide YY and peptide YY agonists for treatment of metabolic disorders
|
US20020077599A1
(en)
*
|
2000-12-19 |
2002-06-20 |
Animas Corporation |
Transcutaneous inserter for low-profile infusion sets
|
US6899898B2
(en)
|
2000-12-21 |
2005-05-31 |
Nektar Therapeutics |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
USD472896S1
(en)
*
|
2000-12-23 |
2003-04-08 |
Andreas Peiker |
Telephone support
|
USD456776S1
(en)
*
|
2001-01-23 |
2002-05-07 |
Datex - Ohmeda, Inc. |
Snap sensor connector
|
WO2002069983A1
(en)
|
2001-03-01 |
2002-09-12 |
Bharat Serums & Vaccines Ltd. |
Amphotericin b aqueous composition
|
WO2002076344A1
(en)
|
2001-03-23 |
2002-10-03 |
Durect Corporation |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
WO2002085428A2
(en)
|
2001-04-19 |
2002-10-31 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US7144863B2
(en)
|
2001-06-01 |
2006-12-05 |
Eli Lilly And Company |
GLP-1 formulations with protracted time action
|
US20020197185A1
(en)
|
2001-06-20 |
2002-12-26 |
Jamiolkowski Dennis D. |
Antimicrobial coatings for medical devices
|
US6514517B2
(en)
|
2001-06-20 |
2003-02-04 |
Ethicon, Inc. |
Antimicrobial coatings for medical devices
|
US20030045454A1
(en)
|
2001-06-21 |
2003-03-06 |
Franklin Okumu |
Sustained release formulation
|
US20030007992A1
(en)
|
2001-06-22 |
2003-01-09 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
US20030104063A1
(en)
|
2001-06-22 |
2003-06-05 |
Babcock Walter C. |
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
|
US7163688B2
(en)
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
WO2003000230A1
(en)
|
2001-06-22 |
2003-01-03 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
US7163697B2
(en)
|
2001-06-22 |
2007-01-16 |
Johns Hopkins University School Of Medicine |
Biodegradable polymer compositions, compositions and uses related thereto
|
US20030138403A1
(en)
|
2001-06-29 |
2003-07-24 |
Maxygen Aps |
Interferon formulations
|
WO2003007981A1
(en)
|
2001-07-20 |
2003-01-30 |
Intermune, Inc. |
Methods of treating liver fibrosis
|
WO2003011892A2
(en)
|
2001-07-31 |
2003-02-13 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Glp-1 exendin-4 peptide analogs and uses thereof
|
US20040198654A1
(en)
|
2001-08-23 |
2004-10-07 |
Wolfgang Glaesner |
Glucagon-like peptide-1analogs
|
US7101843B2
(en)
|
2001-08-23 |
2006-09-05 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
US20030118660A1
(en)
|
2001-08-31 |
2003-06-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
WO2003020245A1
(en)
|
2001-08-31 |
2003-03-13 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US7666835B2
(en)
|
2001-09-07 |
2010-02-23 |
Imperial Innovations Limited |
Oxyntomodulin for preventing or treating excess weight
|
WO2003024357A2
(en)
|
2001-09-14 |
2003-03-27 |
Martin Francis J |
Microfabricated nanopore device for sustained release of therapeutic agent
|
WO2003024503A2
(en)
|
2001-09-17 |
2003-03-27 |
Durect Corporation |
Device and method for accurate delivery of an active agent
|
US20060224145A1
(en)
|
2001-09-17 |
2006-10-05 |
Gillis Edward M |
Device and method for accurate delivery of an active agent
|
US8217001B2
(en)
|
2001-09-24 |
2012-07-10 |
Imperial Innovations Limited |
Modification of feeding behavior
|
US7459432B2
(en)
|
2001-09-24 |
2008-12-02 |
Imperial College Innovations Ltd. |
Modification of feeding behavior
|
WO2003030923A1
(en)
|
2001-10-05 |
2003-04-17 |
Intermune, Inc. |
Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
|
US20040002442A1
(en)
|
2001-10-05 |
2004-01-01 |
Clark Pan |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
US20030078618A1
(en)
|
2001-10-19 |
2003-04-24 |
Fey Kate E. |
System and method for removing implanted devices
|
US20030097121A1
(en)
|
2001-10-24 |
2003-05-22 |
Claude Jolly |
Implantable fluid delivery apparatuses and implantable electrode
|
US20040142902A1
(en)
|
2001-11-08 |
2004-07-22 |
Struijker- Boudier Harry A.J. |
Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
|
US20070248572A1
(en)
|
2001-11-09 |
2007-10-25 |
Intarica Therapeutics, Inc. |
Method for treating diseases with omega interferon
|
WO2003041684A2
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot compositions and uses thereof
|
US20030157178A1
(en)
|
2001-11-14 |
2003-08-21 |
Guohua Chen |
Injectable depot composition
|
US7829109B2
(en)
|
2001-11-14 |
2010-11-09 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
US20030180364A1
(en)
|
2001-11-14 |
2003-09-25 |
Guohua Chen |
Catheter injectable depot compositions and uses thereof
|
US20030170289A1
(en)
|
2001-11-14 |
2003-09-11 |
Guohua Chen |
Injectable depot compositions and uses thereof
|
WO2003041757A2
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Catheter injectable depot compositions and uses thereof
|
US20030191099A1
(en)
|
2001-11-27 |
2003-10-09 |
Schering Ag |
17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
|
US20030108608A1
(en)
|
2001-12-12 |
2003-06-12 |
Erik Laridon |
Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
|
US20030135153A1
(en)
|
2001-12-17 |
2003-07-17 |
Charles Hagemeier |
Drug implant injection device
|
EP1323450A1
(en)
|
2001-12-18 |
2003-07-02 |
Risdon Pharma GmbH |
Syringe device
|
WO2003053400A1
(en)
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
US7141547B2
(en)
|
2001-12-21 |
2006-11-28 |
Human Genome Sciences, Inc. |
Albumin fusion proteins comprising GLP-1 polypeptides
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
US20040029784A1
(en)
|
2002-01-22 |
2004-02-12 |
Hathaway David R. |
Methods and compositions for treating polycystic ovary syndrome
|
WO2003066585A2
(en)
|
2002-02-08 |
2003-08-14 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
US7589169B2
(en)
|
2002-02-27 |
2009-09-15 |
Pharmain Corporation |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US8277776B2
(en)
|
2002-02-27 |
2012-10-02 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US8231859B2
(en)
|
2002-02-27 |
2012-07-31 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US8257682B2
(en)
|
2002-02-27 |
2012-09-04 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US7790140B2
(en)
|
2002-02-27 |
2010-09-07 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
WO2003072133A2
(en)
|
2002-02-28 |
2003-09-04 |
Norferm Da |
Immunostimulatory agent comprising a biomass of methanotrophic bacterium
|
US20050118221A1
(en)
|
2002-02-28 |
2005-06-02 |
William Blakely |
Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
|
WO2003072113A1
(en)
|
2002-02-28 |
2003-09-04 |
Norbrook Laboratories Limited |
Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
|
US20030215515A1
(en)
|
2002-04-11 |
2003-11-20 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by spray drying
|
US6960192B1
(en)
|
2002-04-23 |
2005-11-01 |
Insulet Corporation |
Transcutaneous fluid delivery system
|
US20030220617A1
(en)
|
2002-05-22 |
2003-11-27 |
C. Dickerson Co. |
Safety needle introducer and universal needle protector for vascular access devices
|
US7736665B2
(en)
|
2002-05-31 |
2010-06-15 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
US20140163057A1
(en)
|
2002-05-31 |
2014-06-12 |
Titan Pharmaceuticals, Inc. |
Implantable Polymeric Device for Sustained Release of Buprenorphine
|
US20030233101A1
(en)
|
2002-06-17 |
2003-12-18 |
Senorx, Inc. |
Plugged tip delivery tube for marker placement
|
US20040097906A1
(en)
|
2002-06-17 |
2004-05-20 |
Fereira Pamela J. |
Osmotic delivery system with early zero order push power engine
|
US7074423B2
(en)
|
2002-06-17 |
2006-07-11 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
WO2004002565A1
(en)
|
2002-06-26 |
2004-01-08 |
Alza Corporation |
Minimally compliant, volume efficient piston for osmotic drug delivery systems
|
US7112335B2
(en)
|
2002-06-26 |
2006-09-26 |
Alza Corporation |
Minimally compliant, volume-efficient piston for osmotic drug delivery systems
|
US6939556B2
(en)
|
2002-06-26 |
2005-09-06 |
Alza Corporation |
Minimally compliant, volume efficient piston for osmotic drug delivery systems
|
US20060014678A1
(en)
|
2002-06-28 |
2006-01-19 |
Imperial College Innovations Ltd. |
Modification of feeding behavior
|
US20040001689A1
(en)
|
2002-06-28 |
2004-01-01 |
Intel Corporation |
System and method for improving audio during post-production of video recordings
|
US20040022859A1
(en)
|
2002-07-31 |
2004-02-05 |
Guohua Chen |
Injectable multimodal polymer depot compositions and uses thereof
|
US20040024069A1
(en)
|
2002-07-31 |
2004-02-05 |
Guohua Chen |
Injectable depot compositions and uses thereof
|
US20040215133A1
(en)
|
2002-09-18 |
2004-10-28 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
WO2004026106A2
(en)
|
2002-09-18 |
2004-04-01 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
WO2004036186A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
WO2004035754A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
WO2004035762A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
WO2004034975A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. |
Sustained release profile modification
|
US20040209801A1
(en)
|
2002-10-22 |
2004-10-21 |
Brand Stephen J. |
Treatment of diabetes
|
US20040151753A1
(en)
|
2002-11-06 |
2004-08-05 |
Guohua Chen |
Controlled release depot formulations
|
WO2004046338A2
(en)
|
2002-11-20 |
2004-06-03 |
North Shore-Long Island Jewish Research Institute |
Use of hmgb polypeptides for increasing immune responses
|
US20050009742A1
(en)
|
2002-11-20 |
2005-01-13 |
Goran Bertilsson |
Compounds and methods for increasing neurogenesis
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
US7316680B2
(en)
|
2002-11-21 |
2008-01-08 |
Intarcia Therapeutics, Inc. |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
US20040102762A1
(en)
|
2002-11-21 |
2004-05-27 |
Gilbert Scott Jay |
Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel
|
US7014636B2
(en)
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
WO2004052336A2
(en)
|
2002-12-10 |
2004-06-24 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US20040266683A1
(en)
|
2002-12-17 |
2004-12-30 |
Hathaway David R |
Prevention and treatment of cardiac arrhythmias
|
US20040224903A1
(en)
|
2002-12-19 |
2004-11-11 |
Stephen Berry |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
US8398967B2
(en)
|
2002-12-19 |
2013-03-19 |
Intarcia Therapeutics, Inc. |
Particle formulations for use in pharmaceutical compositions
|
US20090087408A1
(en)
|
2002-12-19 |
2009-04-02 |
Intarcia Therapeutics, Inc. |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
WO2004056338A2
(en)
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
US20080064636A1
(en)
|
2003-01-10 |
2008-03-13 |
Imperial College Innovations Limited |
Modification of Feeding Behaviour
|
US7825091B2
(en)
|
2003-01-10 |
2010-11-02 |
Imperial Innovations Limited |
Modification of feeding behaviour
|
US20040142867A1
(en)
|
2003-01-14 |
2004-07-22 |
Kiyomoto Oi |
Stabilized proteinic preparation
|
US20070149011A1
(en)
|
2003-02-18 |
2007-06-28 |
Medconx, Inc. |
Male medical device electrical connector with engineered friction fit
|
WO2004089335A2
(en)
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
US20050276856A1
(en)
|
2003-03-31 |
2005-12-15 |
Fereira Pamela J |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
US20050008661A1
(en)
|
2003-03-31 |
2005-01-13 |
Fereira Pamela J. |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
US7207982B2
(en)
|
2003-03-31 |
2007-04-24 |
Alza Corporation |
Osmotic pump with means for dissipating internal pressure
|
US20050010196A1
(en)
|
2003-03-31 |
2005-01-13 |
Fereira Pamela J. |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
US20040199140A1
(en)
*
|
2003-04-03 |
2004-10-07 |
Rue Matthew L. |
Implanting device and method of using same
|
US7214206B2
(en)
|
2003-04-03 |
2007-05-08 |
Valera Pharmaceuticals, Inc. |
Implanting device and method of using same
|
WO2004089458A1
(en)
|
2003-04-03 |
2004-10-21 |
Valera Pharmaceuticals, Inc. |
Implanting device and method of using same
|
US20050079200A1
(en)
|
2003-05-16 |
2005-04-14 |
Jorg Rathenow |
Biocompatibly coated medical implants
|
WO2004103342A2
(en)
|
2003-05-16 |
2004-12-02 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
US20050215475A1
(en)
|
2003-05-30 |
2005-09-29 |
John Ong |
Transmucosal delivery of peptides and proteins
|
US20050079202A1
(en)
|
2003-05-30 |
2005-04-14 |
Guohua Chen |
Implantable elastomeric depot compositions and uses thereof
|
US20060178304A1
(en)
|
2003-06-03 |
2006-08-10 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
US20050004557A1
(en)
|
2003-06-12 |
2005-01-06 |
Russell Scott M. |
Orifice device having multiple channels with varying flow rates for drug delivery
|
US20050010942A1
(en)
|
2003-07-09 |
2005-01-13 |
Samsung Electronics Co., Ltd. |
Optical disc drive
|
US20080260838A1
(en)
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
US7241457B2
(en)
|
2003-09-30 |
2007-07-10 |
Alza Corporation |
Osmotically driven active agent delivery device providing an ascending release profile
|
US7407499B2
(en)
|
2003-10-31 |
2008-08-05 |
Intarcia Therapeutics, Inc. |
Osmotic pump with self-retaining, fast-start membrane plug
|
US20050095284A1
(en)
|
2003-10-31 |
2005-05-05 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
US20050101943A1
(en)
|
2003-11-06 |
2005-05-12 |
Alza Corporation |
Modular imbibition rate reducer for use with implantable osmotic pump
|
WO2005048930A2
(en)
|
2003-11-14 |
2005-06-02 |
Alza Corporation |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
WO2005048952A2
(en)
|
2003-11-17 |
2005-06-02 |
Alza Corporation |
Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
|
US8257691B2
(en)
|
2003-11-17 |
2012-09-04 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising a particle formulation and suspending vehicle
|
US20130052237A1
(en)
|
2003-11-17 |
2013-02-28 |
Intarcia Therapeutics, Inc. |
Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations
|
US20050112188A1
(en)
|
2003-11-17 |
2005-05-26 |
Eliaz Rom E. |
Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US20170319470A1
(en)
|
2003-11-17 |
2017-11-09 |
Intarcia Therapeutics, Inc. |
Methods of manufacturing viscous liquid pharmaceutical formulations
|
US7964183B2
(en)
|
2003-11-17 |
2011-06-21 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising a particle formulation and suspending vehicle
|
US20050131386A1
(en)
|
2003-12-15 |
2005-06-16 |
Freeman Lynetta J. |
Method and device for minimally invasive implantation of biomaterial
|
US20050143749A1
(en)
|
2003-12-31 |
2005-06-30 |
Depuy Spine, Inc. |
Inserter instrument and implant clip
|
US20050175701A1
(en)
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
US20060094652A1
(en)
|
2004-02-11 |
2006-05-04 |
Levy Odile E |
Hybrid polypeptides with selectable properties
|
US20060293232A1
(en)
|
2004-02-11 |
2006-12-28 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
US8722037B2
(en)
|
2004-03-19 |
2014-05-13 |
Meck Sharp & Dohme B.V. |
X-ray visible drug delivery device
|
US20070141102A1
(en)
|
2004-03-24 |
2007-06-21 |
N.V. Organon |
Drug delivery system based on polyethylene vinylacetate copolymers
|
US20050271702A1
(en)
|
2004-04-15 |
2005-12-08 |
Wright Steven G |
Polymer-based sustained release device
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US7612176B2
(en)
|
2004-04-15 |
2009-11-03 |
Alkermes, Inc. |
Polymer-based sustained release device
|
EP2133073A1
(en)
|
2004-04-15 |
2009-12-16 |
Amylin Pharmaceuticals, Inc. |
Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
|
US7563871B2
(en)
|
2004-04-15 |
2009-07-21 |
Alkermes, Inc. |
Polymer-based sustained release device
|
WO2005110425A1
(en)
|
2004-04-15 |
2005-11-24 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20070166352A1
(en)
|
2004-04-15 |
2007-07-19 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20090247463A1
(en)
|
2004-04-15 |
2009-10-01 |
Alkermes, Inc. |
Polymer-based sustained release device
|
WO2005102293A1
(en)
|
2004-04-15 |
2005-11-03 |
Amylin Pharmaceuticals, Inc. |
Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
|
US20080112994A1
(en)
|
2004-05-25 |
2008-05-15 |
Intarcia Therapeutics, Inc. |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
EP1600187B1
(en)
|
2004-05-27 |
2009-01-21 |
Cordis Corporation |
Orifice device having multiple channels with varying flow rates for drug delivery
|
US20090042781A1
(en)
|
2004-06-28 |
2009-02-12 |
Novo Nordisk A/S |
Methods for Treating Diabetes
|
WO2006017772A1
(en)
|
2004-08-05 |
2006-02-16 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
US20060030526A1
(en)
|
2004-08-05 |
2006-02-09 |
Kui Liu |
Stable suspension formulations of erythropoietin receptor agonists
|
WO2006023526A2
(en)
|
2004-08-18 |
2006-03-02 |
Waters Investments Limited |
Defined leak path for high pressure seal
|
US20080110515A1
(en)
|
2004-08-18 |
2008-05-15 |
Waters Investments Limited |
Defined Lead Path For High Pressure Seal
|
US20090163447A1
(en)
|
2004-08-25 |
2009-06-25 |
Maggio Edward T |
Compositions for Drug Administration
|
US20060094693A1
(en)
|
2004-09-21 |
2006-05-04 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
US20060073182A1
(en)
|
2004-10-01 |
2006-04-06 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
US20060084604A1
(en)
|
2004-10-19 |
2006-04-20 |
Chieko Kitaura |
Transepithelial delivery of peptides with incretin hormone activities
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
US7604647B2
(en)
|
2004-10-22 |
2009-10-20 |
Medical Instrument Development Laboratories, Inc. |
Ophthalmic cannula insertion tool and method
|
US20080207512A1
(en)
|
2004-11-01 |
2008-08-28 |
Amylin Pharmaceuticals, Inc. |
Methods for Treating Obesity and Obesity Related and Disorders
|
US20090156474A1
(en)
|
2004-11-01 |
2009-06-18 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity and obesity related diseases and disorders
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060160736A1
(en)
|
2004-12-30 |
2006-07-20 |
Diakine Therapeutics, Inc. |
Pharmaceutical compositions and methods for restoring beta-cell mass and function
|
US7393827B2
(en)
|
2004-12-30 |
2008-07-01 |
Diakine Therapeutics, Inc. |
Pharmaceutical compositions and methods for restoring β-cell mass and function
|
USD608447S1
(en)
*
|
2005-01-14 |
2010-01-19 |
Edwards Lifesciences Corporation |
Sensor case
|
WO2006077242A1
(en)
|
2005-01-24 |
2006-07-27 |
N.V. Organon |
Applicator for inserting an implant
|
US20100298807A1
(en)
|
2005-01-24 |
2010-11-25 |
Akzo Nobel N.V. |
Applicator for inserting an implant
|
WO2006077250A1
(en)
|
2005-01-24 |
2006-07-27 |
N.V. Organon |
Applicator for inserting an implant
|
US8888745B2
(en)
|
2005-01-24 |
2014-11-18 |
Merck Sharp & Dohme B.V. |
Applicator for inserting an implant
|
WO2006081279A2
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
TW200634060A
(en)
|
2005-02-03 |
2006-10-01 |
Alza Corp |
Solvent/polymer solutions as suspension vehicles
|
US9526763B2
(en)
|
2005-02-03 |
2016-12-27 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20170368145A1
(en)
|
2005-02-03 |
2017-12-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery device comprising an insulinotropic peptide and uses thereof
|
US20170348392A1
(en)
|
2005-02-03 |
2017-12-07 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles
|
WO2006084139A2
(en)
|
2005-02-03 |
2006-08-10 |
Intarcia Therapeutics, Inc. |
An implantable interferon-containing device
|
US8273365B2
(en)
|
2005-02-03 |
2012-09-25 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US8470353B2
(en)
|
2005-02-03 |
2013-06-25 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US8992962B2
(en)
|
2005-02-03 |
2015-03-31 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20120178687A1
(en)
|
2005-02-03 |
2012-07-12 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US8460694B2
(en)
|
2005-02-03 |
2013-06-11 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20170181964A1
(en)
|
2005-02-03 |
2017-06-29 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US7655254B2
(en)
|
2005-02-03 |
2010-02-02 |
Intarcia Therapeutics, Inc. |
Implantable device for continuous delivery of interferon
|
US8211467B2
(en)
|
2005-02-03 |
2012-07-03 |
Intarcia Therapeutics, Inc. |
Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
|
US8206745B2
(en)
|
2005-02-03 |
2012-06-26 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US8440226B2
(en)
|
2005-02-03 |
2013-05-14 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US9682127B2
(en)
|
2005-02-03 |
2017-06-20 |
Intarcia Therapeutics, Inc. |
Osmotic delivery device comprising an insulinotropic peptide and uses thereof
|
US20070281024A1
(en)
|
2005-02-03 |
2007-12-06 |
Alza Corporation |
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
|
US20170056476A1
(en)
|
2005-02-03 |
2017-03-02 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles
|
US9539200B2
(en)
|
2005-02-03 |
2017-01-10 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20060216242A1
(en)
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
US8158150B2
(en)
|
2005-02-03 |
2012-04-17 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US8114437B2
(en)
|
2005-02-03 |
2012-02-14 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20060263433A1
(en)
|
2005-02-03 |
2006-11-23 |
Ayer Rupal A |
Suspension formulation of interferon
|
US8052996B2
(en)
|
2005-02-03 |
2011-11-08 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20110264077A1
(en)
|
2005-02-03 |
2011-10-27 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US8940316B2
(en)
|
2005-02-03 |
2015-01-27 |
Intarcia Therapeutics, Inc. |
Osmotic delivery comprising an insulinotropic peptide and uses thereof
|
US9095553B2
(en)
|
2005-02-03 |
2015-08-04 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20060193918A1
(en)
|
2005-02-03 |
2006-08-31 |
Rohloff Catherine M |
Solvent/polymer solutions as suspension vehicles
|
US8299025B2
(en)
|
2005-02-03 |
2012-10-30 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20150231062A1
(en)
|
2005-02-03 |
2015-08-20 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20080260840A1
(en)
|
2005-02-03 |
2008-10-23 |
Alessi Thomas R |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20100297209A1
(en)
|
2005-02-03 |
2010-11-25 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20130034210A1
(en)
|
2005-02-03 |
2013-02-07 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles
|
US20110104111A1
(en)
|
2005-02-03 |
2011-05-05 |
Intarcia Therapeutics, Inc. |
Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
|
US20060251618A1
(en)
|
2005-02-03 |
2006-11-09 |
Paula Dennis |
Implantable device for continuous delivery of interferon
|
US8367095B2
(en)
|
2005-02-03 |
2013-02-05 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
WO2006086727A2
(en)
|
2005-02-09 |
2006-08-17 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
US20090286723A1
(en)
|
2005-02-11 |
2009-11-19 |
Amylin Pharmaceuticals, Inc. |
Hybrid Polypeptides with Selectable Properties
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
US20090036364A1
(en)
|
2005-02-11 |
2009-02-05 |
Amylin Pharmaceuticals, Inc. |
Gip analog and hybrid polypeptides with selectable properties
|
US20080312157A1
(en)
|
2005-02-11 |
2008-12-18 |
Amylin Pharmaceuticals, Inc. |
Gip analog and hybrid polypeptides with selectable properties
|
US8202836B2
(en)
|
2005-03-09 |
2012-06-19 |
Imperial Innovations Limited |
Modified PYY (3-36) peptides and their effects on feeding behavior
|
US8114430B2
(en)
|
2005-03-15 |
2012-02-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
WO2006101815A2
(en)
|
2005-03-15 |
2006-09-28 |
Alza Corporation |
Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems
|
US20060246138A1
(en)
|
2005-03-15 |
2006-11-02 |
Rohloff Catherine M |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US8278267B2
(en)
|
2005-03-31 |
2012-10-02 |
Amylin Pharmaceuticals, Llc |
Method of modifying food preference comprising administering amylin or amylin agonist
|
US7879794B2
(en)
|
2005-03-31 |
2011-02-01 |
Amylin Pharmaceuticals, Inc. |
Methods for controlling binge eating disorders
|
US20080200383A1
(en)
|
2005-04-08 |
2008-08-21 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
|
WO2006111169A1
(en)
|
2005-04-21 |
2006-10-26 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
US20060264890A1
(en)
|
2005-05-06 |
2006-11-23 |
Medtronic Minimed, Inc. |
Needle inserter and method for infusion device
|
WO2006131730A1
(en)
|
2005-06-06 |
2006-12-14 |
Camurus Ab |
Glp-1 analogue formulations
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
US20080269725A1
(en)
|
2005-07-22 |
2008-10-30 |
Trent Deem |
Osmotically Driven Dispense Pump and Related Components for Use in High Pressure Applications
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US20090312246A1
(en)
|
2005-08-19 |
2009-12-17 |
Amylin Pharmaceuticals, Inc. |
Uses of Glucoregulatory Proteins
|
WO2007024700A2
(en)
|
2005-08-19 |
2007-03-01 |
Amylin Pharmaceuticals, Inc. |
Exendin for treating diabetes and reducing body weight
|
WO2007056681A2
(en)
|
2005-11-04 |
2007-05-18 |
Smithkline Beecham Corporation |
Methods for administering hypoglycemic agents
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
US20070207958A1
(en)
|
2005-11-09 |
2007-09-06 |
Bridon Dominique P |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
US20090209460A1
(en)
|
2005-12-16 |
2009-08-20 |
Amylin Pharmaceuticals, Inc. |
Compositions and methods for treating obesity and related metabolic disorders
|
WO2007084460A2
(en)
|
2006-01-18 |
2007-07-26 |
Qps, Llc |
Pharmaceutical compositions with enhanced stability
|
US20090012463A1
(en)
|
2006-01-19 |
2009-01-08 |
N.V. Organon |
Kit for and method of assembling an applicator for inserting an implant
|
WO2007082889A1
(en)
|
2006-01-19 |
2007-07-26 |
N.V. Organon |
Kit for and method of assembling an applicator for inserting an implant
|
US20090186817A1
(en)
|
2006-03-21 |
2009-07-23 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
US20090074734A1
(en)
|
2006-05-02 |
2009-03-19 |
Actogenix N.V. |
Microbial intestinal delivery of obesity related peptides
|
WO2007133778A2
(en)
|
2006-05-12 |
2007-11-22 |
Amylin Pharmaceuticals, Inc. |
Methods to restore glycemic control
|
WO2007140416A2
(en)
|
2006-05-30 |
2007-12-06 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
EP2020990B1
(en)
|
2006-05-30 |
2010-09-22 |
Intarcia Therapeutics, Inc |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US8263736B2
(en)
|
2006-07-03 |
2012-09-11 |
Imperial Innovations Limited |
Compounds and their effects on feeding behaviour
|
US20080020016A1
(en)
|
2006-07-11 |
2008-01-24 |
Quest Pharmaceutical Services, Llc |
Pharmaceutical compositions for sustained release delivery of peptides
|
US20100144621A1
(en)
|
2006-08-04 |
2010-06-10 |
Dennis Kim |
Use of Exendins and Exendin Agonists and GLP-1 Receptor Agonists for Altering the Concentration of Fibrinogen
|
US20100185184A1
(en)
|
2006-08-09 |
2010-07-22 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
US20080091176A1
(en)
|
2006-08-09 |
2008-04-17 |
Alessi Thomas R |
Osmotic delivery systems and piston assemblies for use therein
|
US7879028B2
(en)
|
2006-08-09 |
2011-02-01 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
WO2008021133A2
(en)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
US20110166554A1
(en)
|
2006-08-09 |
2011-07-07 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
US20140378900A1
(en)
|
2006-08-09 |
2014-12-25 |
Intarcia Therapeutics, Inc. |
Osmotic Delivery Systems and Piston Assemblies for Use Therein
|
US8801700B2
(en)
|
2006-08-09 |
2014-08-12 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
US7682356B2
(en)
|
2006-08-09 |
2010-03-23 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein
|
WO2008041245A2
(en)
|
2006-10-05 |
2008-04-10 |
Panacea Biotec Ltd. |
Injectable depot composition and it's process of preparation
|
US8845726B2
(en)
*
|
2006-10-18 |
2014-09-30 |
Vertiflex, Inc. |
Dilator
|
US20090125030A1
(en)
*
|
2006-10-18 |
2009-05-14 |
Shawn Tebbe |
Dilator
|
US7632256B2
(en)
|
2006-10-24 |
2009-12-15 |
Mosler Theodore J |
Catheter gripping device
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
US8101576B2
(en)
|
2006-12-13 |
2012-01-24 |
Imperial Innovations Limited |
Compounds and their effects on feeding behaviour
|
WO2008086086A2
(en)
|
2007-01-05 |
2008-07-17 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
|
USD555589S1
(en)
*
|
2007-01-23 |
2007-11-20 |
Intec, Inc. |
Battery charger and game controller cradle
|
US20090022727A1
(en)
|
2007-01-26 |
2009-01-22 |
Alza Corp. |
Injectable, nonaqueous suspension with high concentration of therapeutic agent
|
US20080208194A1
(en)
*
|
2007-02-13 |
2008-08-28 |
Christine Bickenbach |
Double cut shaver
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US8556861B2
(en)
*
|
2007-04-23 |
2013-10-15 |
Sid Technologies, Llc |
Methods and devices for intradermal injection
|
WO2008134425A1
(en)
|
2007-04-27 |
2008-11-06 |
Cedars-Sinai Medical Center |
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
|
US20090202481A1
(en)
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Composition for Sustained Release Delivery of Proteins or Peptides
|
US20150111818A1
(en)
|
2008-02-13 |
2015-04-23 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US20090202608A1
(en)
|
2008-02-13 |
2009-08-13 |
Alessi Thomas R |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US8343140B2
(en)
|
2008-02-13 |
2013-01-01 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US9572889B2
(en)
|
2008-02-13 |
2017-02-21 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US8926595B2
(en)
|
2008-02-13 |
2015-01-06 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US20170079906A1
(en)
|
2008-02-13 |
2017-03-23 |
Intarcia Therapeutics Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US20090210019A1
(en)
|
2008-02-14 |
2009-08-20 |
Dennis Dong-Won Kim |
Treatment of excess weight by neural downregulation in combination with compositions
|
WO2009109927A2
(en)
|
2008-03-05 |
2009-09-11 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
US20090234392A1
(en)
|
2008-03-13 |
2009-09-17 |
Depuy Spine, Inc. |
Method for inserting a spinal fixation element using implants having guide tabs
|
US20090254143A1
(en)
|
2008-04-04 |
2009-10-08 |
Tweden Katherine S |
Methods and systems for glucose regulation
|
WO2009143285A2
(en)
|
2008-05-21 |
2009-11-26 |
Amylin Pharmaceuticals, Inc. |
Exendins to lower cholestrol and triglycerides
|
US20100105627A1
(en)
|
2008-09-17 |
2010-04-29 |
Paul Salama |
Pharmaceutical compositions and related methods of delivery
|
US20160030337A1
(en)
|
2008-09-30 |
2016-02-04 |
Braeburn Pharmaceuticals Bvba Sprl |
Implantable device for the delivery of risperidone and methods of use thereof
|
US9078900B2
(en)
|
2008-09-30 |
2015-07-14 |
Braeburn Pharmaceuticals Bvba Sprl |
Implantable device for the delivery of risperidone and methods of use thereof
|
US20100094252A1
(en)
|
2008-10-14 |
2010-04-15 |
Medtronic, Inc. |
Subcutaneous delivery tool
|
WO2010045169A1
(en)
|
2008-10-14 |
2010-04-22 |
Medtronic, Inc. |
Subcutaneous delivery tool
|
US20160022582A1
(en)
|
2008-10-15 |
2016-01-28 |
Intarcia Therapeutics, Inc. |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
NZ592113A
(en)
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
US20170119854A1
(en)
|
2008-10-15 |
2017-05-04 |
Intarcia Therapeutics, Inc. |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
US20100092566A1
(en)
|
2008-10-15 |
2010-04-15 |
Alessi Thomas R |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
USD638478S1
(en)
*
|
2009-07-06 |
2011-05-24 |
Performance Designed Products Llc |
Video game controller accessory
|
US8858621B2
(en)
*
|
2009-07-23 |
2014-10-14 |
Edwards Lifesciences Corporation |
Methods of implanting a prosthetic heart valve
|
USD810289S1
(en)
*
|
2009-09-14 |
2018-02-13 |
Bayer Oy |
Inserter
|
US20160354305A1
(en)
|
2009-09-28 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US8298561B2
(en)
|
2009-09-28 |
2012-10-30 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US20130030417A1
(en)
|
2009-09-28 |
2013-01-31 |
Intarcia Therapeutics, Inc. |
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
|
US20110076317A1
(en)
|
2009-09-28 |
2011-03-31 |
Alessi Thomas R |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US20120265232A1
(en)
*
|
2009-10-23 |
2012-10-18 |
Andrea Surbone |
Guide tube for tattoo machine needles
|
US8815802B2
(en)
|
2009-12-16 |
2014-08-26 |
Novo Nordisk A/S |
GLP-1 analogues and derivatives
|
US20110152181A1
(en)
|
2009-12-22 |
2011-06-23 |
Eli Lilly And Company |
Oxyntomodulin peptide analogue
|
US20110152182A1
(en)
|
2009-12-22 |
2011-06-23 |
Eli Lilly And Company |
Oxyntomodulin peptide analogue
|
US20110306549A1
(en)
|
2010-06-09 |
2011-12-15 |
Amylin Pharmaceuticals, Inc. |
Glp-1 receptor agonists to treat pancreatitis
|
USD669589S1
(en)
|
2010-08-31 |
2012-10-23 |
Koninklijke Philips Electronics N.V. |
Blood system cartridge
|
US8747412B2
(en)
|
2011-02-14 |
2014-06-10 |
Imds Corporation |
System and method for bone anchor removal
|
US20170252409A1
(en)
|
2011-02-16 |
2017-09-07 |
Intarcia Therapeutics, Inc. |
Compositions, devices and methods of use thereof for the treatment of cancers
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US20150057227A1
(en)
|
2011-02-16 |
2015-02-26 |
Intarcia Therapeutics, Inc. |
Compositions, devices and methods of use thereof for the treatment of cancers
|
US20120303045A1
(en)
|
2011-05-26 |
2012-11-29 |
Derm Instruments & Innovations Llc |
Skin removal instrument
|
WO2013004983A1
(en)
|
2011-07-04 |
2013-01-10 |
Imperial Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
USD678889S1
(en)
*
|
2011-10-04 |
2013-03-26 |
Avision Inc. |
Scanner docking station
|
US20140058409A1
(en)
|
2012-04-19 |
2014-02-27 |
Removaid As |
Device for removing an item implanted underneath the skin
|
GB2501400A
(en)
|
2012-04-19 |
2013-10-23 |
Removaid As |
Tool for removing a subcutaneous implant
|
US20130296661A1
(en)
|
2012-05-04 |
2013-11-07 |
Pacesetter, Inc. |
System and method for implanting a physiologic sensor assembly
|
US20130324977A1
(en)
|
2012-06-04 |
2013-12-05 |
Medtronic, Inc. |
Transcutaneous implant tools, systems and methods
|
WO2013184235A1
(en)
|
2012-06-04 |
2013-12-12 |
Medtronic, Inc. |
Transcutaneous implant tools, systems and methods
|
USD805199S1
(en)
*
|
2012-06-21 |
2017-12-12 |
Importla, Llc |
Tattoo tube
|
US9332995B2
(en)
|
2012-09-25 |
2016-05-10 |
Russo Inventions, Llc |
Bone-harvesting tool
|
US9241722B2
(en)
*
|
2012-10-08 |
2016-01-26 |
Warsaw Orthopedic, Inc. |
Surgical pin guide and methods of use
|
US20150297509A1
(en)
|
2012-11-19 |
2015-10-22 |
Braeburn Pharmaceuticals Bvba Sprl |
Implantable drug delivery compositions and methods of treatment thereof
|
US20140148837A1
(en)
*
|
2012-11-28 |
2014-05-29 |
Richard M. Levitan |
Surgical device for cricothyrotomy and the like
|
US20140324067A1
(en)
*
|
2013-01-09 |
2014-10-30 |
Senseonics, Incorporated |
Subcutaneous tunneling and implantation tools for a disk-shaped sensor
|
US20140236162A1
(en)
|
2013-02-19 |
2014-08-21 |
Mark Barongan |
Apparatus for Removing Devices Implanted in the Body
|
USD750764S1
(en)
*
|
2014-04-08 |
2016-03-01 |
Bootz Manufacturing Company |
Shower pan
|
USRE46577E1
(en)
*
|
2014-06-05 |
2017-10-24 |
Deka Products Limited Partnership |
Enclosure for a peritoneal dialysis device
|
US20150359553A1
(en)
|
2014-06-16 |
2015-12-17 |
Med-El Elektromedizinische Geraete Gmbh |
Implant magnet insertion and removal tools
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
USD819820S1
(en)
*
|
2015-04-24 |
2018-06-05 |
Otto Bock Healthcare Products Gmbh |
Part of prosthesis
|
US20160354115A1
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
USD789539S1
(en)
*
|
2015-07-09 |
2017-06-13 |
Spinal Surgical Strategies, Llc |
Fusion cage
|
USD789540S1
(en)
*
|
2016-01-29 |
2017-06-13 |
Veterinary Implants Direct, Llc. |
Orthopedic plate
|
US20170273706A1
(en)
*
|
2016-03-24 |
2017-09-28 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
US9931133B2
(en)
*
|
2016-03-24 |
2018-04-03 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
US20180009871A1
(en)
|
2016-05-16 |
2018-01-11 |
Intarcia Therapeutics Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
US20180193059A1
(en)
*
|
2017-01-10 |
2018-07-12 |
Electronics And Telecommunications Research Institute |
Automatic hair follicle transplant apparatus
|
USD816843S1
(en)
*
|
2017-06-07 |
2018-05-01 |
Alevio, Llc |
Orthopedic implant
|